These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which
registered |
|
common share |
|
|
|
|
|
par value per common share |
|
|
|
|
|
Large accelerated filer
¨
|
Accelerated filer
¨
|
|
x
|
|
|
|
Emerging growth company
|
|
|
●
|
the size and growth potential of the markets for our products, and our ability to serve those markets;
|
|
●
|
the rate and degree of market acceptance of our products;
|
|
●
|
our ability to expand our sales organization to address effectively existing and new markets that we intend to target;
|
| iii |
|
●
|
impact from future regulatory, judicial, and legislative changes or developments in the U.S. and foreign countries;
|
|
●
|
our ability to compete effectively in a competitive industry;
|
|
●
|
our ability to obtain funding for our operations and effectively utilize the capital raised therefrom;
|
|
●
|
our ability to attract collaborators and strategic partnerships;
|
|
●
|
our ability to meet the continued listing requirements and standards of the Nasdaq Capital Market, or Nasdaq;
|
|
●
|
our ability to meet our financial operating objectives;
|
|
●
|
the availability of, and our ability to attract, qualified employees for our business operations;
|
|
●
|
general business and economic conditions;
|
|
●
|
our ability to meet our financial obligations as they become due;
|
|
●
|
positive cash flows and financial viability of our operations and any new business opportunities;
|
|
●
|
our ability to secure intellectual property rights over our proprietary products or enter into license agreements to secure the legal use of certain patents and intellectual property;
|
|
●
|
our ability to be successful in new markets;
|
|
●
|
our ability to avoid infringement of intellectual property rights; and
|
|
●
|
the effects of the global COVID-19 pandemic.
|
| iv |
|
[Reserved]
|
|
Capitalization and Indebtedness
|
|
Reasons for the Offer and Use of Proceeds
|
|
Risk Factors
|
|
●
|
We have a history of operating losses and we may never achieve or maintain profitability.
|
|
●
|
Our auditor has included a “going concern” explanatory paragraph in its report on our consolidated financial statements for the fiscal year ended December 31, 2021, expressing substantial doubt about our ability to continue as an ongoing business for the next twelve months. Our consolidated financial statements do not include any adjustments that may result from the outcome of this uncertainty. If we cannot secure the financing needed to continue as a viable business, our shareholders may lose some or all of their investment in us.
|
|
●
|
In 2021, our independent registered public accountants identified five material weaknesses in our internal controls over financial reporting. If we are unable to remediate these material weaknesses, we may not be able to report our financial results accurately, prevent fraud or file our periodic reports as a public company in a timely manner. In 2020, our independent registered public accountants identified six material weaknesses in our internal controls over financial reporting, which have only been partially remediated.
|
|
●
|
We rely on our channel partners to generate a substantial majority of our revenues. If these channel partners fail to perform or if we cannot enter into agreements with channel partners on favorable terms, our operating results could be significantly harmed.
|
|
●
|
We are materially dependent on the adoption of our solutions by both the industrial enterprise and public sector markets, and if end customers in those markets do not purchase our solutions, our revenues will be adversely impacted, and we may not be able to expand into other markets.
|
| 1 |
|
●
|
We participate in a competitive industry, which may become more competitive. Competitors with greater resources and significant experience in high-volume product manufacturing may be able to respond more quickly and cost-effectively than we can to new or emerging technologies and changes in customer requirements.
|
|
●
|
Defects in our products could reduce demand for our products and result in a loss of sales, delay in market acceptance and injury to our reputation, which would adversely impact our business.
|
|
●
|
If our business does not grow as we expect, or if we fail to manage our growth effectively, our operating results and business would suffer.
|
|
●
|
The markets for our devices and related accessories may not develop as quickly as we expect, or may not develop at all. Our dependence on our cellular carrier channel partners and their success in promoting Push to Talk over Cellular to their client base is key for the success of the business.
|
|
●
|
Our future success is dependent on our ability to create independent brand awareness for our company and products with end customers, and our inability to achieve such brand awareness could limit our prospects.
|
|
●
|
We are dependent on the continued services and performance of a concentrated group of senior management and other key personnel, the loss of any of whom could adversely impact our business
.
|
|
●
|
We compete in a rapidly evolving market, and the failure to respond quickly and effectively to changing market requirements could cause our business and operating results to decline.
|
|
●
|
If we are unable to sell our solutions into new markets, our revenues may not grow.
|
|
●
|
If we are unable to attract, integrate and retain additional qualified personnel, including top technical talent, our business could be adversely impacted.
|
|
●
|
A security breach or other significant disruption of our information technology (“IT”) systems or those of our partners, suppliers or manufacturers, caused by cyberattacks or other means, could have a negative impact on our operations, sales, and operating results.
|
|
●
|
We experience lengthy sales cycles for our products and the delay of an expected large order could result in a significant unexpected revenue shortfall.
|
|
●
|
We have a limited history of high-volume commercial production of our devices, and we may face manufacturing capacity constraints.
|
|
●
|
We face risks related to novel Coronavirus (COVID-19) which could significantly disrupt our research and development, operations, sales, supply chain and financial results.
|
|
●
|
As we work with multiple vendors for our components, if we fail to adequately forecast demand for our inventory and supply needs, we could incur additional costs or experience manufacturing delays, which could reduce our gross margin or cause us to delay or even lose sales.
|
|
●
|
Our dependence on third-party suppliers for key components of our products could delay shipment of our products and reduce our sales.
|
|
●
|
Because we rely on a small number of channel partners/customers for a large portion of our revenue, the loss of any of these customers would have a material adverse effect on our operating results and cash flows.
|
| 2 |
|
●
|
If dedicated public safety LTE networks are not deployed at the rate we anticipate or at all, demand for our solutions may not grow as expected.
|
|
●
|
The application development ecosystem supporting our devices and related accessories is new and evolving.
|
|
●
|
Failure of our suppliers, subcontractors, distributors, resellers, and representatives to use acceptable legal or ethical business practices, or to fail for any other reason, could negatively impact our business.
|
|
●
|
Our products are subject to risks associated with sourcing and manufacturing.
|
|
●
|
The nature of our business may result in undesirable press coverage or other negative publicity, which would adversely impact our brand identity, future sales and results of operations.
|
|
●
|
Changes in the availability of federal funding to support local public safety or other public sector efforts could impact our opportunities with public sector end customers.
|
|
●
|
Economic uncertainties or downturns, or political changes, could limit the availability of funds available to our customers and potential customers, which could significantly adversely impact our business.
|
|
●
|
Natural or man-made disasters and other similar events may significantly disrupt our business, and negatively impact our operating results and financial condition.
|
|
●
|
We are exposed to risks associated with strategic acquisitions and investments.
|
|
●
|
We could be adversely impacted by changes in accounting standards and subjective assumptions, estimates and judgments by management related to complex accounting matters.
|
|
●
|
We are subject to anti-corruption, anti-bribery, anti-money laundering, economic sanctions, export control, and similar laws. Non- compliance with such laws can subject us to criminal or civil liability and harm our business, revenues, financial condition and results of operations.
|
|
●
|
We are subject to a wide range of product regulatory and safety, consumer, worker safety and environmental laws and regulations.
|
|
●
|
Changes in laws and regulations concerning the use of telecommunication bandwidth could increase our costs and adversely impact our business.
|
|
●
|
We are subject to a wide range of privacy and data security laws, regulations and other legal obligations.
|
|
●
|
The effects of the Tax Cuts and Jobs Act on our business have not yet been fully analyzed and could harm our results of operations.
|
|
●
|
If we are unable to successfully protect our intellectual property, our competitive position may be harmed.
|
|
●
|
Others may claim that we infringe on their intellectual property rights, which may result in costly and time-consuming litigation and could delay or otherwise impair the development and commercialization of our products.
|
|
●
|
Our use of open source software could subject us to possible litigation or otherwise impair the development of our products.
|
| 3 |
|
●
|
Our inability to obtain and maintain any third-party license required to develop new products and product enhancements could seriously harm our business, financial condition and results of operations.
|
|
●
|
Conditions in Israel could materially and adversely affect our business.
|
|
●
|
Because we are a corporation incorporated in British Columbia and some of our directors and officers are resident in Canada, it may be difficult for investors in the United States to enforce civil liabilities against us based solely upon the federal securities laws of the United States. Similarly, it may be difficult for Canadian investors to enforce civil liabilities against our directors and officers residing outside of Canada.
|
|
●
|
We have operations in China, which exposes us to risks inherent in doing business there.
|
|
●
|
The impact of potential changes in customs, tariffs, and trade policies in the United States and the potential corresponding actions by other countries, including recent trade initiatives announced by the U.S. presidential administration against China, in which we do business could adversely impact our financial performance.
|
|
●
|
Operating outside of the United States presents specific risks to our business, and we have substantial operations outside of the United States.
|
|
●
|
Foreign currency fluctuations may reduce our competitiveness and sales in foreign markets.
|
|
●
|
We may require additional capital to fund our business and support our growth, and our inability to generate and obtain such capital on acceptable terms, or at all, could harm our business, operating results, financial condition and prospects. In addition, such funding may dilute our existing shareholders.
|
|
●
|
We expect that our stock price will fluctuate significantly, and you may not be able to resell your shares at or above the public offering price you paid for your shares.
|
|
●
|
The conversion of the Lind Partner Note and the exercise of the Lind Partner Warrant or future sales of our Common Shares may further dilute the Common Shares and adversely impact the price of our Common Shares.
|
|
●
|
If we are not able to comply with the applicable continued listing requirements or standards of Nasdaq, Nasdaq could delist our Common Shares and Warrants which could negatively impact the price of our securities and an investor’s ability to sell them.
|
|
●
|
If we fail to maintain proper and effective internal controls, our ability to produce accurate financial statements on a timely basis could be impaired.
|
|
●
|
We will continue to incur significant increased costs as a result of operating as a public company in the United States, and our management will be required to devote substantial time to new compliance initiatives.
|
|
●
|
Because we are a foreign private issuer and are exempt from certain Nasdaq corporate governance standards applicable to U.S. issuers, you will have less protection than you would have if we were a domestic issuer.
|
|
●
|
We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.
|
|
●
|
Our executive officers and directors, and their affiliated entities, along with our two other largest stockholders, own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval.
|
| 4 |
| 5 |
|
●
|
On a quarterly basis, the Company now reviews inventory on hand for slow moving merchandise and reviews inventory on hand regularly.
For the year ended 2021, it was determined that $4,659,648 (2020- $1,571,649) of the inventory was impaired due to slow movement. The accessories and spare parts related to these products amounted to $839,693 (2020 - $316,000), which was also impaired.
|
|
●
|
The Company now reviews quantities on hand before approving purchase orders.
|
|
●
|
As of April 1, 2022, the Company signed a lease for their own exclusive warehouse space so that outside contract warehouses will not be required.
|
|
●
|
The Company now reviews product returns to compare and ensure that they occur in the same fiscal year.
|
|
●
|
The Company’s controller scrutinizes all revenues earned in the period to ensure compliance with IFRS15.
|
|
●
|
The Company’s controller and CFO in Canada coordinates full scheduling of the year end process to ensure timely close off of accounting periods.
|
|
●
|
The Company now requires a formal signed distribution agreement with major customers which define the terms, including payment terms, return policy, repair policy and warranty policy.
|
|
●
|
The Company is reviewing the credit risk of each customer and a part of the sales function has the formalized distribution agreements in place.
|
|
●
|
On a quarterly basis, management is reviewing inventory on hand for slow moving merchandise and reviews inventory on hand regularly.
|
|
●
|
The Company has engaged outside consultants to review purchase price adjustment valuation, impairment valuations and complex transactions to ensure compliance with IFRS standards.
|
|
●
|
The Company has improved its internal financial reporting communication process. The Company has streamlined the communications between the Company’s Israel and Canadian-based financial reporting groups. Furthermore, the Company’s Audit Committee adopted a policy requiring the Company’s Canadian CFO to meet with the Company’s Israel-based reporting group at least twice a year to ensure that the Israel reporting group’s policies and procedures are consistent with those in Canada and that all the inventory is properly tracked and procedures for intercompany transactions must follow our existing formal standard procedures. We believe that these measures should ensure that for the 2022 fiscal year, our financial controls will be remediated.
|
| 6 |
|
●
|
The Audit Committee will ensure that at the quarterly financial meetings, there will be an agenda item to discuss policies and procedures in place in ensure internal control compliance with respect to intercompany transactions and returns so that all documentation is clear, consistent and that they are recorded in a timely manner and the pricing policy is consistent.
|
|
(i)
|
documenting and formally assessing our accounting and financial reporting policies and procedures; and
|
|
(ii)
|
increasing the use of third-party consultants in assessing significant accounting transactions and other technical accounting and financial reporting issues, preparing accounting memoranda addressing these issues and maintaining these memoranda in our corporate records.
|
|
|
●
|
AT&T, in the United States;
|
|
|
●
|
FirstNet, in the United States;
|
|
|
●
|
Verizon, in the United States;
|
|
|
●
|
Rogers, in Canada;
|
|
|
●
|
a leading global LMR vendor and distributor in North America and international markets;
|
|
|
●
|
Partner Communications, in Israel; and
|
|
|
●
|
Cellcom, in Israel.
|
| 7 |
| 8 |
|
|
●
|
accelerate the adoption of our solutions by new end customers;
|
|
|
●
|
expand into new vertical markets;
|
|
|
●
|
develop and deliver new products and services;
|
| 9 |
|
|
●
|
increase awareness of the benefits that our solutions offer; and
|
|
|
●
|
expand our domestic and international footprint.
|
|
|
●
|
evolving industry standards;
|
|
|
●
|
frequent new product and service introductions;
|
|
|
●
|
increasing demand for customized product and software solutions;
|
|
|
●
|
rapid competitive developments;
|
|
|
●
|
changing customer demands; and
|
|
|
●
|
evolving distribution channels.
|
| 10 |
| 11 |
| 12 |
| 13 |
| 14 |
| 15 |
|
|
●
|
increased shipping costs;
|
|
|
●
|
the imposition of additional import or trade restrictions;
|
|
|
●
|
legal or economic restrictions on overseas suppliers’ ability to produce and deliver products;
|
|
|
●
|
increased custom duties and tariffs;
|
|
|
●
|
unforeseen delays in customs clearance of goods;
|
|
|
●
|
more restrictive quotas;
|
|
|
●
|
loss of a most favored nation trading status;
|
|
|
●
|
currency exchange rates;
|
|
|
●
|
transportation delays;
|
|
|
●
|
port of entry issues; and
|
|
|
●
|
foreign government regulations, political instability and economic uncertainties in the countries from which we or our suppliers source our products.
|
| 16 |
| 17 |
|
|
●
|
problems integrating and divesting the operations, technologies, personnel, services or products over geographically disparate locations;
|
|
|
●
|
unanticipated costs, taxes, litigation and other contingent liabilities;
|
|
|
●
|
continued liability for discontinued businesses and pre-closing activities of divested businesses or certain post-closing liabilities which we may agree to assume as part of the transaction in which a particular business is divested;
|
|
|
●
|
adverse impacts on existing business relationships with suppliers and customers;
|
|
|
●
|
cannibalization of revenues as customers may seek multi-product discounts;
|
|
|
●
|
risks associated with entering into markets in which we have no, or limited, prior experience;
|
|
|
●
|
incurrence of significant restructuring charges if acquired products or technologies are unsuccessful;
|
|
|
●
|
significant diversion of management’s attention from our core business and diversion of key employees’ time and resources;
|
|
|
●
|
licensing, indemnity or other conflicts between existing businesses and acquired businesses;
|
|
|
●
|
inability to retain key customers, distributors, suppliers, vendors and other business relations of the acquired business; and
|
|
|
●
|
potential loss of our key employees or the key employees of an acquired organization or as a result of discontinued businesses.
|
| 18 |
| 19 |
| 20 |
| 21 |
| 22 |
| 23 |
| 24 |
| 25 |
|
|
●
|
effectively managing and overseeing operations that are distant and remote from corporate headquarters may be difficult and may impose increased operating costs;
|
|
|
●
|
fluctuating foreign currency rates could restrict sales, increase costs of purchasing, and impact collection of receivables outside of the United States;
|
|
|
●
|
volatility in foreign credit markets may affect the financial well-being of our customers and suppliers;
|
|
|
●
|
violations of anti-corruption laws, including the Foreign Corrupt Practices Act and the U.K. Bribery Act could result in large fines and penalties;
|
| 26 |
|
|
●
|
violations of privacy and data security laws could result in large fines and penalties; and
|
|
|
●
|
tax disputes with foreign taxing authorities, and any resultant taxation in foreign jurisdictions associated with operations in such jurisdictions, including with respect to transfer pricing practices associated with such operations.
|
|
|
●
|
foreign governments may impose burdensome tariffs, quotas, taxes, trade barriers, or capital flow restrictions;
|
|
|
●
|
restrictions on the export or import of technology may reduce or eliminate the ability to sell in or purchase from certain markets;
|
|
|
●
|
political and economic instability, including deterioration of political relations between the United States and other countries, may reduce demand for our solutions or put our non-U.S. assets at risk;
|
|
|
●
|
potentially limited intellectual property protection in certain countries may limit recourse against infringing on our solutions or cause us to refrain from selling in certain geographic territories;
|
|
|
●
|
staffing may be difficult along with higher turnover at international operations;
|
|
|
●
|
a government-controlled exchange rate and limitations on the convertibility of currencies, including the Chinese yuan;
|
|
|
●
|
transportation delays and customs related delays that may affect production and distribution of our products; and
|
|
|
●
|
integration and enforcement of laws vary significantly among jurisdictions and may change significantly over time.
|
| 27 |
|
|
●
|
market conditions in the broader stock market in general, or in our industry in particular;
|
|
|
●
|
actual or anticipated fluctuations in our quarterly financial and operating results;
|
|
|
●
|
introduction of new products and services by us or our competitors;
|
|
|
●
|
sales, or anticipated sales, of large blocks of our stock;
|
|
|
●
|
issuance of new or changed securities analysts’ reports or recommendations;
|
|
|
●
|
failure of industry or securities analysts to maintain coverage of our company, changes in financial estimates by any industry or securities analysts that follow our company, or our failure to meet such estimates;
|
|
|
●
|
additions or departures of key personnel;
|
|
|
●
|
regulatory or political developments;
|
|
|
●
|
changes in accounting principles or methodologies;
|
|
|
●
|
acquisitions by us or by our competitors;
|
|
|
●
|
litigation and governmental investigations; and
|
|
|
●
|
economic, political and geopolitical conditions or events.
|
| 28 |
| 29 |
| 30 |
|
●
|
a limited availability for market quotations for our securities;
|
|
●
|
reduced liquidity with respect to our securities;
|
|
●
|
a determination that our Common Share is a “penny stock,” which will require brokers trading in our Common Share to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our Common Share;
|
|
●
|
limited amount of news and analyst coverage; and
|
|
●
|
a decreased ability to issue additional securities or obtain additional financing in the future.
|
| 31 |
|
History and Development of the Company
|
| 32 |
| 33 |
| 34 |
|
Business Overview
|
|
●
|
Cost
. These LMR devices are typically expensive and generally consisting of older and outdated technology (which may also cause its users to incur additional costs).
|
|
●
|
Range of Communication
. LMR devices are also limited in their range of communication, as local radio bandwidth is limited. As a result, most devices are restricted to communications in one metro area with limited connectivity with neighboring areas, agencies or companies, thereby hindering headquarters’ ability to communicate with their vehicles. For instance, on occasion, vehicles communicating through LMR will often encounter a communication “dead zone”, thus hindering these vehicles’ ability to communicate during times of emergencies.
|
| 35 |
|
●
|
Limited Features
. LMR devices are usually single-purpose devices, allowing for communications through “push-to-talk,” or PTT, broadcasting with limited additional features. LMR devices are limited in their range of communication, as local radio bandwidth is limited. Most devices are restricted to communications in metro areas with limited connectivity with neighboring areas, agencies or companies, hindering headquarters’ ability to communicate with their vehicles. Occasionally, vehicles communicating through LMR will often encounter a communication “dead zone”, thus hindering these vehicles’ abilities to communicate during times of emergencies.
|
| 36 |
|
|
●
|
Android Operating System Compatibility
. Android compatibility allows customers to download apps such as a PTT app and have it configured by the wireless carrier to ensure its workers can communicate one-to-one, or in a full group call. Because virtually any Android fleet application can be downloaded, this enables customers to eliminate redundant single-purpose hardware in their fleet vehicles.
|
|
|
●
|
Noise Cancelation
. Superior loud and clear audio in noisy commercial vehicles. Our bundled kit includes a dedicated loud speaker and microphone for both phone calls and PTT calls.
|
|
|
●
|
Economic
. Far lower price to customers compared to using multiple single purpose devices which can cost thousands of dollars to purchase, and which can be time consuming to install and maintain. With our UV350, the commercial vehicle only needs one sim card with a voice and data plan as opposed to using multiple devices with multiple sims and plans.
|
|
|
●
|
Safety
. With its large display, a dedicated palm mic and one-touch buttons for key driver tasks, we believe the UV350 is safe for drivers, allowing them to keep their eyes on the road and hands on the wheel.
|
|
|
●
|
Wi-Fi Hotspot
. Customers can connect up to five devices to the UV350 via Wi-Fi, giving the customers added connectivity options.
|
|
|
●
|
Always Powered
. The UV350 is powered by the vehicle’s battery so it automatically powers on when the vehicle is started up, and it defaults to turn off automatically when the vehicle is turned off. This default setting can be changed for customers who need the device to stay on after the vehicle is shut off. The device is designed to operate properly in any extreme temperature situation.
|
|
|
●
|
4G LTE
. The UV350 works on the multiple wireless carrier networks which provide the best nation-wide coverage options for customers and is compatible with high speed 4G LTE data networks.
|
|
|
●
|
Accessories
. In addition to the UV350 standard bundle kit which includes everything that customers need to get started, we also offer optional PTT accessories such as a Wired Palm Mic which most PTT customers prefer. For customers whose fleet vehicles travel into areas with limited cellular reception, we offer an outdoor, roof mounted antenna as well as an optional in-line cellular booster to amplify the cellular signal so that fleet vehicles can maintain connection when they are further away from cellular tower sites.
|
|
|
●
|
Tough & Rugged
. Our rugged devices meet the industry standards for ruggedness and water resistance.
|
|
|
●
|
Large PTT Button
. With a large dedicated PTT Button, we believe that access to our PTT feature is simplified, as opposed to having to hold down a virtual button on the screen.
|
| 37 |
|
|
●
|
Loud and Clear
. Its powerful speakers ensure loud, clear audio sound quality.
|
|
|
●
|
Large Battery
. Long lasting battery to keep working for several days, in most customer use cases. The battery can be easily and quickly replaced on short notice.
|
|
|
●
|
SOS Button
. Workers can alert supervisors of emergency situations that occur on the job.
|
| 38 |
| 39 |
| 40 |
| 41 |
|
i.
|
RF Passive Bypass technology enables tethered devices to communicate through the amplifier network, even if the amplifier loses power, or when the signal is not required, a key differentiator amongst competitors, in particular for mission-critical applications and first responder vehicles that require constant clear cellular coverage and connectivity.
|
|
ii.
|
Auto Gain & Oscillation Control detects the level of incoming signal strength and self-adjusts output power to ensure maximum signal strength. This feature is vital for telematics (mobile) M2M applications because the amplifier will be in constant motion and will require periodic self-adjustment based on changing incoming signal environment.
|
|
Organizational Structure
|
|
Name of Subsidiary
|
|
Principal Activities
|
|
|
Place of Incorporation
|
|
Ownership
|
|
|
|
Queensgate Resources Corp.
|
|
|
|
|
British Columbia, Canada
|
|
|
100
|
%
|
|
Queensgate Resources US Corp.
|
|
|
|
|
Nevada, USA
|
|
|
100
|
%
|
|
Siyata Mobile (Canada) Inc.
|
|
|
|
|
British Columbia, Canada
|
|
|
100
|
%
|
|
Siyata Mobile Israel Ltd.
|
|
|
|
|
Israel
|
|
|
100
|
%
|
|
Signifi Mobile Inc.
|
|
|
|
|
Quebec, Canada
|
|
|
100
|
%
|
|
ClearRF Nevada Ltd.
|
|
|
|
|
Nevada, USA
|
|
|
100
|
%
|
| 42 |
|
Property, Plant and Equipment
|
|
Operating Results
|
| 43 |
| 44 |
| 45 |
|
|
|
Quarter Ended
|
|
|||||||||||||||||||||||||||||
|
|
|
Dec 31,
2021 |
|
|
Sep 30,
2021 |
|
|
Jun 30,
2021 |
|
|
Mar 31,
2021 |
|
|
Dec 31,
2020 |
|
|
Sep 30,
2020 |
|
|
Jun 30,
2020 |
|
|
Mar 31,
2020 |
|
||||||||
|
Income/(loss)
|
|
$
|
(4,979,661
|
)
|
|
$
|
(5,667,937
|
)
|
|
$
|
(10,862,538
|
)
|
|
$
|
(2,115,406
|
)
|
|
$
|
(9,911,960
|
)
|
|
$
|
(1,881,981
|
)
|
|
$
|
(627,004
|
)
|
|
$
|
(1,170,172
|
)
|
|
Comprehensive income/(loss) for the period
|
|
$
|
(4,833,795
|
)
|
|
$
|
(5,677,274
|
)
|
|
$
|
(10,927,718
|
)
|
|
$
|
(2,047,991
|
)
|
|
$
|
(9,247,116
|
)
|
|
$
|
(1,870,348
|
)
|
|
$
|
(1,016,568
|
)
|
|
$
|
(1,454,198
|
)
|
|
Loss per share
|
|
$
|
(0.99
|
)
|
|
$
|
(1.18
|
)
|
|
$
|
(2.26
|
)
|
|
$
|
(0.45
|
)
|
|
$
|
(3.08
|
)
|
|
$
|
(1.92
|
)
|
|
$
|
(0.73
|
)
|
|
$
|
(1.35
|
)
|
| 46 |
| 47 |
| 48 |
| 49 |
| 50 |
| 51 |
|
Liquidity and Capital Resources
|
| 52 |
|
(a)
|
Authorized
Unlimited number of common shares without par value
|
|
(b)
|
Common share transactions
|
| 53 |
|
|
|
Number of Stock
Options |
|
|
Weighted Average
Exercise Price |
|
||
|
Outstanding options, December 31, 2018
|
|
|
65,448
|
|
|
$
|
49.00
|
|
|
Granted
|
|
|
17,655
|
|
|
|
59.01
|
|
|
Expired
|
|
|
(518
|
)
|
|
|
65.57
|
|
|
Outstanding options, December 31, 2019
|
|
|
82,585
|
|
|
$
|
52.34
|
|
|
Granted
|
|
|
279,190
|
|
|
|
6.47
|
|
|
Expired/Cancelled
|
|
|
(33,707
|
)
|
|
|
39.79
|
|
|
Outstanding options, December 31, 2020
|
|
|
328,068
|
|
|
$
|
13.99
|
|
|
Granted
|
|
|
100,500
|
|
|
|
11.50
|
|
|
Expired/Cancelled
|
|
|
(14,000
|
)
|
|
|
16.38
|
|
|
Outstanding options, December 31, 2021
|
|
|
414,568
|
|
|
$
|
13.88
|
|
| 54 |
|
Grant Date
|
|
Number of
options outstanding |
|
|
Number of
options exercisable |
|
|
Weighted Average
Exercise Price |
|
|
Expiry date
|
|
Remaining
contractual life (years) |
|
||||
|
1-Jan-17
|
|
|
2,207
|
|
|
|
2,207
|
|
|
$
|
40.00
|
|
|
1-Jan-22
|
|
|
0.01
|
*
|
|
11-Jan-17
|
|
|
2,483
|
|
|
|
2,483
|
|
|
|
41.00
|
|
|
11-Jan-22
|
|
|
0.03
|
*
|
|
4-Apr-17
|
|
|
6,897
|
|
|
|
6,897
|
|
|
|
63.00
|
|
|
4-Apr-22
|
|
|
0.26
|
|
|
24-Jul-17
|
|
|
690
|
|
|
|
690
|
|
|
|
79.00
|
|
|
18-Feb-22
|
|
|
0.13
|
*
|
|
24-Jul-17
|
|
|
7,929
|
|
|
|
7,929
|
|
|
|
79.00
|
|
|
24-Jul-22
|
|
|
0.56
|
|
|
24-Dec-18
|
|
|
12,896
|
|
|
|
12,896
|
|
|
|
57.00
|
|
|
24-Dec-23
|
|
|
1.98
|
|
|
24-Dec-18
|
|
|
1,724
|
|
|
|
1,724
|
|
|
|
57.00
|
|
|
18-Feb-22
|
|
|
0.13
|
*
|
|
15-Jan-19
|
|
|
828
|
|
|
|
828
|
|
|
|
57.00
|
|
|
15-Jan-24
|
|
|
2.04
|
|
|
21-Mar-19
|
|
|
12,345
|
|
|
|
12,345
|
|
|
|
63.00
|
|
|
21-Mar-24
|
|
|
2.22
|
|
|
1-Jan-20
|
|
|
2,069
|
|
|
|
1,380
|
|
|
|
57.00
|
|
|
1-Jan-24
|
|
|
2.00
|
|
|
15-Nov-20
|
|
|
95,000
|
|
|
|
59,375
|
|
|
|
6.00
|
|
|
15-Nov-30
|
|
|
8.88
|
|
|
15-Nov-20
|
|
|
161,500
|
|
|
|
100,938
|
|
|
|
6.00
|
|
|
15-Nov-25
|
|
|
3.88
|
|
|
15-Nov-20
|
|
|
20,000
|
|
|
|
20,000
|
|
|
|
6.00
|
|
|
18-Feb-22
|
|
|
0.13*
|
|
|
2-Jan-21
|
|
|
57,000
|
|
|
|
28,500
|
|
|
|
11.50
|
|
|
2-Jan-26
|
|
|
4.01
|
|
|
2-Jan-21
|
|
|
5,000
|
|
|
|
2,500
|
|
|
|
11.50
|
|
|
2-Jan-31
|
|
|
8.01
|
|
|
18-Jan-21
|
|
|
14,500
|
|
|
|
7,250
|
|
|
|
11.50
|
|
|
18-Jan-26
|
|
|
4.05
|
|
|
18-Jan-21
|
|
|
1,500
|
|
|
|
1,500
|
|
|
|
11.50
|
|
|
31-Aug-22
|
|
|
0.67
|
|
|
18-Jan-21
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
11.50
|
|
|
29-Oct-22
|
|
|
0.83
|
|
|
Total
|
|
|
414,568
|
|
|
|
279,442
|
|
|
$
|
13.88
|
|
|
|
|
|
4.52
|
|
|
Grant Date
|
|
Number of
options outstanding |
|
|
Number of
options exercisable |
|
|
Weighted Average
Exercise Price |
|
|
Expiry date
|
|
Remaining
contractual life (years) |
|
||||
|
4-Apr-17
|
|
|
6,897
|
|
|
|
6,897
|
|
|
|
63.00
|
|
|
4-Apr-22
|
|
|
0.02
|
|
|
24-Jul-17
|
|
|
7,929
|
|
|
|
7,929
|
|
|
|
79.00
|
|
|
24-Jul-22
|
|
|
0.32
|
|
|
24-Dec-18
|
|
|
12,896
|
|
|
|
12,896
|
|
|
|
57.00
|
|
|
24-Dec-23
|
|
|
1.73
|
|
|
15-Jan-19
|
|
|
828
|
|
|
|
828
|
|
|
|
57.00
|
|
|
15-Jan-24
|
|
|
1.79
|
|
|
21-Mar-19
|
|
|
12,345
|
|
|
|
12,345
|
|
|
|
63.00
|
|
|
21-Mar-24
|
|
|
1.98
|
|
|
1-Jan-20
|
|
|
2,069
|
|
|
|
1,380
|
|
|
|
57.00
|
|
|
1-Jan-24
|
|
|
1.75
|
|
|
15-Nov-20
|
|
|
95,000
|
|
|
|
59,375
|
|
|
|
6.00
|
|
|
15-Nov-30
|
|
|
8.63
|
|
|
15-Nov-20
|
|
|
161,500
|
|
|
|
100,938
|
|
|
|
6.00
|
|
|
15-Nov-25
|
|
|
3.63
|
|
|
2-Jan-21
|
|
|
57,000
|
|
|
|
28,500
|
|
|
|
11.50
|
|
|
2-Jan-26
|
|
|
3.76
|
|
|
2-Jan-21
|
|
|
5,000
|
|
|
|
2,500
|
|
|
|
11.50
|
|
|
2-Jan-31
|
|
|
7.76
|
|
|
18-Jan-21
|
|
|
14,500
|
|
|
|
7,250
|
|
|
|
11.50
|
|
|
18-Jan-26
|
|
|
3.8
|
|
|
18-Jan-21
|
|
|
1,500
|
|
|
|
1,500
|
|
|
|
11.50
|
|
|
31-Aug-22
|
|
|
0.42
|
|
|
18-Jan-21
|
|
|
10,000
|
|
|
|
10,000
|
|
|
|
11.50
|
|
|
29-Oct-22
|
|
|
0.58
|
|
|
18-Mar-22
|
|
|
795,000
|
|
|
|
66,250
|
|
|
|
1.03
|
|
|
18-Mar-25
|
|
|
2.97
|
|
|
Total
|
|
|
1,182,464
|
|
|
|
318,588
|
|
|
$
|
5.24
|
|
|
|
|
|
4.16
|
|
| 55 |
|
|
|
Number of
options |
|
|
Weighted
average exercise price |
|
||
|
Outstanding agent options, December 31, 2018
|
|
|
8,050
|
|
|
$
|
47.91
|
|
|
Granted
|
|
|
5,025
|
|
|
|
45.58
|
|
|
Exercised
|
|
|
(5,668
|
)
|
|
|
43.71
|
|
|
Expired
|
|
|
(810
|
)
|
|
|
53.00
|
|
|
Outstanding agent options, December 31, 2019
|
|
|
6,597
|
|
|
$
|
52.68
|
|
|
Granted
|
|
|
445,926
|
|
|
|
7.36
|
|
|
Outstanding agent options, December 31, 2020
|
|
|
452,523
|
|
|
|
8.02
|
|
|
Expired
|
|
|
(6,597
|
)
|
|
|
52.68
|
|
|
Outstanding agent options, December 31, 2021
|
|
|
445,926
|
|
|
$
|
7.51
|
|
|
Grant Date
|
|
Number of
options outstanding |
|
|
Number of
options exercisable |
|
|
Weighted
Average Exercise Price |
|
|
Expiry date
|
|
Remaining
contractual life (years) |
|
||||
|
28-Jul-20
|
|
|
1,702
|
|
|
|
1,702
|
|
|
$
|
20.49
|
|
|
28-Jul-22
|
|
|
0.57
|
|
|
29-Sep-20
|
|
|
113,500
|
|
|
|
113,500
|
|
|
$
|
6.60
|
|
|
28-Sep-25
|
|
|
3.75
|
|
|
29-Sep-20
|
|
|
266,000
|
|
|
|
266,000
|
|
|
$
|
6.85
|
|
|
28-Sep-25
|
|
|
3.75
|
|
|
31-Dec-20
|
|
|
64,724
|
|
|
|
64,724
|
|
|
$
|
11.50
|
|
|
30-Jun-24
|
|
|
2.50
|
|
|
Total
|
|
|
445,926
|
|
|
|
445,926
|
|
|
|
7.51
|
|
|
3.56
|
|
|||
|
Grant Date
|
Number of options
outstanding |
Number of options
exercisable |
Weighted Average
Exercise Price |
Expiry
date |
Remaining contractual
life (years) |
|||||||||||||||
|
28-Jul-20
|
1,702
|
1,702
|
$
|
20.49
|
28-Jul-22
|
0.33
|
||||||||||||||
|
29-Sep-20
|
113,500
|
113,500
|
$
|
6.60
|
28-Sep-25
|
3.50
|
||||||||||||||
|
29-Sep-20
|
266,000
|
266,000
|
$
|
6.85
|
28-Sep-25
|
3.50
|
||||||||||||||
|
31-Dec-20
|
64,724
|
64,724
|
$
|
11.50
|
30-Jun-24
|
2.25
|
||||||||||||||
|
11-Jan-22
|
434,783
|
0
|
$
|
2.53
|
11-Jan-27
|
4.79
|
||||||||||||||
|
Total
|
880,709
|
445,926
|
$
|
5.05
|
4.04
|
|||||||||||||||
| 56 |
|
o
|
During the year, 68,647 share purchase warrants expired at an average price of $62.87.
|
|
o
|
In February 2021, 88,911 tradeable warrants were exercised at $6.85 for total proceeds of $609,040.
|
|
o
|
In October 2021, 205,504 tradeable warrants were exercised at $6.85 for total proceeds of $1,407,702.
|
|
o
|
On December 7, 2021, 250,000 warrants were exercised at $4.00 for total proceeds of $1,000,000 and the proportionate fair value of $385,190 of the underlying warrants on the date of the exercise was also transferred to share capital.
|
|
o
|
See Note 15 of the financial statements for warrants issued in the debenture financing. These warrants have met the criteria of a liability instrument on these financial statements.
|
|
|
|
Number of
Warrants |
|
|
Weighted average exercise price
|
|
||
|
|
|
|
|
|
|
|
||
|
Outstanding, December 31, 2018
|
|
|
149,674
|
|
|
$
|
60.16
|
|
|
Granted
|
|
|
80,110
|
|
|
|
54.64
|
|
|
Exercised
|
|
|
(80,865
|
)
|
|
|
54.64
|
|
|
Expired
|
|
|
(36,920
|
)
|
|
|
73.22
|
|
|
Outstanding, December 31, 2019
|
|
|
111,999
|
|
|
$
|
59.02
|
|
|
Granted
|
|
|
3,479,534
|
|
|
|
8.96
|
|
|
Outstanding, December 31, 2020
|
|
|
3,591,533
|
|
|
$
|
10.55
|
|
|
Granted
|
|
|
2,142,857
|
|
|
|
4.00
|
|
|
Exercised
|
|
|
(544,415
|
)
|
|
|
5.54
|
|
|
Expired
|
|
|
(68,647
|
)
|
|
|
62.87
|
|
|
Outstanding, December 31, 2021
|
|
|
5,121,328
|
|
|
$
|
7.64
|
|
| 57 |
|
Grant Date
|
|
Number of
Warrants outstanding and exercisable |
|
|
Exercise Price
|
|
|
Expiry date
|
|
|||
|
23-Dec-19
|
|
|
54,248
|
|
|
|
51.22
|
|
|
|
23-Dec-22
|
|
|
28-Jul-20
|
|
|
74,138
|
|
|
|
20.49
|
|
|
|
28-Jul-22
|
|
|
29-Sep-20
|
|
|
1,805,585
|
|
|
|
6.85
|
|
|
|
28-Sep-25
|
|
|
31-Dec-20
|
|
|
1,294,500
|
|
|
|
11.50
|
|
|
|
30-Jun-24
|
|
|
26-Oct-21
|
|
|
1,892,857
|
|
|
|
4.00
|
|
|
|
3-Nov-26
|
|
|
Total
|
|
|
5,121,328
|
|
|
$
|
7.64
|
|
|
|
||
|
Grant Date
|
|
Number of
Warrants outstanding and exercisable |
|
|
Exercise Price
|
|
|
Expiry date
|
|
|||
|
23-Dec-19
|
|
|
54,248
|
|
|
|
51.22
|
|
|
|
23-Dec-22
|
|
|
28-Jul-20
|
|
|
74,138
|
|
|
|
20.49
|
|
|
|
28-Jul-22
|
|
|
29-Sep-20
|
|
|
1,805,585
|
|
|
|
6.85
|
|
|
|
28-Sep-25
|
|
|
31-Dec-20
|
|
|
1,294,500
|
|
|
|
11.50
|
|
|
|
30-Jun-24
|
|
|
3-Nov-21
|
|
|
1,892,857
|
|
|
|
2.30
|
|
|
|
3-Nov-26
|
|
|
11-Jan-22
|
|
|
9,999,999
|
|
|
|
2.30
|
|
|
|
10-Jan-27
|
|
|
Total
|
|
|
15,121,327
|
|
|
$
|
3.90
|
|
|
|
||
| 58 |
|
Type
|
Valuation Technique
|
Key Inputs
|
Inter-relationship between significant inputs and fair value measurement
|
|
Convertible Promissory Note
|
The fair value of the convertible promissory note has been calculated using a binomial lattice methodology
|
Key observable inputs
·
Share price (December 31, 2021: US $3.70)
·
Risk-free interest rate (December 31, 2021: 0.67%)
·
Dividend yield (December 31, 2021: 0%)
Key unobservable inputs
·
Instrument specific spread (December 31, 2021: 45%)
·
Credit spread (December 31, 2021: 9.76%)
|
The estimated fair value would increase (decrease) if:
·
The share price was higher (lower)
·
The risk-free interest rate was higher (lower)
·
The dividend yield was lower (higher)
·
The instrument specific spread was lower (higher)
·
The credit spread was lower (higher)
|
|
|
|
Comprehensive loss
|
|
|||||
|
|
|
Increase
|
|
|
Decrease
|
|
||
|
Expected volatility (10% movement vs. the model input)
|
|
|
32,775
|
|
|
|
(96,413
|
)
|
|
Credit spread (10% movement vs. the model input)
|
|
|
(265,377
|
)
|
|
|
297,216
|
|
|
Instrument specific spread (10% movement vs. the model input)
|
|
|
(265,377
|
)
|
|
|
297,216
|
|
| 59 |
|
(in thousands)
|
|
December 31, 2021
|
|
|
December 31, 2020
|
|
||
|
EMEA
|
|
$
|
879
|
|
|
$
|
1,246
|
|
|
Australia
|
|
|
119
|
|
|
|
-
|
|
|
North America
|
|
|
546
|
|
|
|
1,491
|
|
|
Total
|
|
$
|
1,544
|
|
|
$
|
2,737
|
|
| 60 |
|
a)
|
Currency Risk
|
|
(in USD thousands)
|
|
USD
|
|
|
NIS
|
|
|
CAD
|
|
|
Total
|
|
||||
|
Financial assets and financial liabilities:
|
|
|
||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
||||||
|
Current assets
|
|
|
||||||||||||||
|
Cash
|
|
|
1,004
|
|
|
|
484
|
|
|
|
132
|
|
|
|
1,620
|
|
|
Trade and other receivables
|
|
|
428
|
|
|
|
840
|
|
|
|
276
|
|
|
|
1,544
|
|
|
Advances to supplier
|
|
|
470
|
|
|
|
-
|
|
|
|
-
|
|
|
|
470
|
|
|
Long term receivable
|
|
|
-
|
|
|
|
168
|
|
|
|
-
|
|
|
|
168
|
|
|
Current liabilities
|
|
|
||||||||||||||
|
Bank loan
|
|
|
-
|
|
|
|
(27
|
)
|
|
|
-
|
|
|
|
(27
|
)
|
|
Accounts payable and accrued liabilities
|
|
|
(309
|
)
|
|
|
(992
|
)
|
|
|
(1,345
|
)
|
|
|
(2,646
|
)
|
|
Due to related party
|
|
|
-
|
|
|
|
-
|
|
|
|
0
|
|
||||
|
Future purchase consideration
|
|
|
(350
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(350
|
)
|
|
Convertible debentures
|
|
|
(3,343
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(3,343
|
)
|
|
Warrant liability
|
|
|
(2,177
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(2,177
|
)
|
|
Total
|
|
|
(4,277
|
)
|
|
|
473
|
|
|
|
(937
|
)
|
|
|
(4,741
|
)
|
|
10% fluctuation in exchange rate
|
|
|
(428
|
)
|
|
|
47
|
|
|
|
(94
|
)
|
|
|
(474
|
)
|
|
a)
|
Interest Rate Risk
|
|
b)
|
Price Risk
|
| 61 |
|
i)
|
Critical accounting estimates
|
|
·
|
Income taxes - Tax provisions are based on enacted or substantively enacted laws. Changes in those laws could affect amounts recognized in profit or loss both in the period of change, which would include any impact on cumulative provisions, and future periods. Deferred tax assets, if any, are recognized to the extent it is considered probable that those assets will be recoverable. This involves an assessment of when those deferred tax assets are likely to reverse.
|
|
·
|
Fair value of stock options and warrants - Determining the fair value of warrants and stock options requires judgments related to the choice of a pricing model, the estimation of stock price volatility, the expected forfeiture rate and the expected term of the underlying instruments. Any changes in the estimates or inputs utilized to determine fair value could have a significant impact on the Company’s future operating results or on other components of shareholders’ equity.
|
|
·
|
Capitalization of development costs and their amortization rate – Development costs are capitalized in accordance with the accounting policy. To determine the amounts earmarked for capitalization, management estimates the cash flows which are expected to be derived from the asset for which the development is carried out and the expected benefit period.
|
|
·
|
Inventory - Inventory is valued at the lower of cost and net realizable value. Cost of inventory includes cost of purchase (purchase price, import duties, transport, handling, and other costs directly attributable to the acquisition of inventories), cost of conversion, and other costs incurred in bringing the inventories to their present location and condition. Net realizable value for inventories is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Provisions are made in profit or loss of the current period on any difference between book value and net realizable value.
|
|
·
|
Estimated product returns - Revenue from product sales is recognized net of estimated sales discounts, credits, returns, rebates and allowances. The return allowance is determined based on an analysis of the historical rate of returns, industry return data, and current market conditions, which is applied directly against sales.
|
|
·
|
Impairment of non-financial assets - The Company assesses impairment at each reporting date by evaluating conditions specific to the Company that may lead to asset impairment. The recoverable amount of an asset or a cash-generating unit (“CGU”) is determined using the greater of fair value less costs to sell and value in use which requires the use of various judgments, estimates, and assumptions.
|
|
·
|
Useful life of intangible assets – The Company estimates
the useful life used to amortize
intangible
assets which relates to the expected future performance of the assets acquired based on management estimate of the sales forecast.
|
|
·
|
Future purchase consideration -
In a business combination, the Company recognizes a contingent consideration at fair value at the acquisition date. Contingent consideration classified as an asset or liability that is a financial instrument and within the scope of IAS 39 Financial Instruments: Recognition and Measurement, is measured at fair value with changes in fair value recognized either in profit or loss, or as a change to other comprehensive income (“OCI”). If the contingent consideration is not within the scope of IAS 39, it is measured at fair value in accordance with the appropriate IFRS. Contingent consideration that is classified as equity is not re-measured and subsequent settlement is accounted for within equity.
|
|
·
|
Contingent consideration from an asset acquisition is recognized when: the conditions associated with the contingency are met; the Company has a present legal or constructive obligation that can be estimated reliably; and it is probably that an outflow of economic benefits will be required to settle the obligation.
|
| 62 |
|
ii)
|
Critical accounting judgments
|
|
·
|
Deferred income taxes – judgments are made by management to determine the likelihood of whether deferred income tax assets at the end of the reporting period will be realized from future taxable earnings. To the extent that assumptions regarding future profitability change, there can be an increase or decrease in the amounts recognized in respect of deferred tax assets as well as the amounts recognized in profit or loss in the period in which the change occurs.
|
|
·
|
Functional currency - The functional currency for the Company and each of the Company’s subsidiaries is the currency of the primary economic environment in which the respective entity operates. The Company has determined the functional currency of each entity to be the Canadian dollar with the exception of Siyata Israel which has the functional currency of the US dollar. Such determination involves certain judgments to identify the primary economic environment. The Company reconsiders the functional currency of its subsidiaries if there is a change in events and/or conditions that determine the primary economic environment.
|
|
·
|
Going concern – As disclosed in Note 1 to the consolidated financial statements.
|
|
|
|
2021
|
|
|
2020
|
|
|
2019
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||
|
Payments to key management personnel:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries, consulting and directors’ fees
|
|
$
|
1,271,532
|
|
|
$
|
1,179,762
|
|
|
$
|
928,637
|
|
|
Share-based payments
|
|
|
235,737
|
|
|
|
261,794
|
|
|
|
656.895
|
|
|
Total
|
|
$
|
1,507,269
|
|
|
$
|
1,441,556
|
|
|
$
|
1,585,532
|
|
|
|
|
|
|
(in thousands)
|
|
|||||||||
|
Type of Service
|
|
Nature of Relationship
|
|
2021
|
|
|
2020
|
|
|
2019
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Selling and marketing expenses
|
|
VP Technology/VP Sales International
|
|
|
402
|
|
|
|
174
|
|
|
|
210
|
|
|
General and administrative expense
|
|
Companies controlled by the CEO, CFO and Directors
|
|
|
869
|
|
|
|
1,006
|
|
|
|
718
|
|
| 63 |
|
Off-Balance Sheet Arrangements
|
|
Directors and Senior Management
|
|
Name
|
|
Age
|
|
Position(s)
|
|
Marc Seelenfreund
|
|
51
|
|
Chief Executive Officer
|
|
Gerald Bernstein
|
|
59
|
|
Chief Financial Officer
|
|
Glenn Kennedy
|
|
54
|
|
Vice President of Sales
|
|
Gidi Bracha
|
|
44
|
|
Vice President of Technology and Product Development
|
|
Luisa Ingargiola*
|
|
52
|
|
Director
|
|
Peter Goldstein
|
|
58
|
|
Director and Chairman of the Board of Directors
|
|
Michael Kron
|
|
58
|
|
Director
|
|
Steven Ospalak
|
|
53
|
|
Director
|
|
Lourdes Felix**
|
|
53
|
|
Director
|
| 64 |
| 65 |
| 66 |
|
Compensation
|
|
USD
|
|
Salary
|
|
|
Bonus
|
|
|
Option
Awards |
|
|
Total
|
|
||||
|
Gerald Bernstein
|
|
$
|
249,750
|
|
|
$
|
23,500
|
|
|
|
6,478
|
|
|
$
|
279,728
|
|
|
Marc Seelenfreund
(2)
|
|
|
334,610
|
|
|
|
0
|
|
|
|
168,149
|
|
|
|
503,029
|
|
|
Gidi Bracha
|
|
|
214,212
|
|
|
|
0
|
|
|
|
14,133
|
|
|
|
228,345
|
|
|
Glenn Kennedy
(3)
|
|
|
120,000
|
|
|
|
17,500
|
|
|
|
46,707
|
|
|
|
184,207
|
|
|
Total
|
|
$
|
918,572
|
|
|
$
|
41,000
|
|
|
$
|
235,737
|
|
|
$
|
1,195,309
|
|
|
(1)
|
Represents the aggregate grant date fair value computed in accordance with IFRS 2 Share-based payments. The price for each amount is based on the closing price of the trading price of our shares on the TSXV on the date of grant.
|
|
(2)
|
Includes 5,000 options at $11.50 per share issued on January 2, 2021.
|
|
(3)
|
Includes 6,000 options at $11.50 per share issued on January 18, 2021.
|
|
Name
|
|
Number of
securities underlying unexercised options (#) |
|
|
Equity
incentive plan awards: Number of securities underlying unexercised unearned options (#) |
|
|
Option
exercise price $USD |
|
|
Option
expiration date |
|
|
Number
of shares or units of stock that have not vested (#) |
|
|
Market
value of shares of units of stock that have not vested ($) |
|
|
Equity
incentive plan awards: Number of unearned shares, units or other rights that have not vested (#) |
|
|
Equity
incentive plan awards: Market or payout value of unearned shares, units or other rights that have not vested ($) |
|
||||||||
|
Marc Seelenfreund
|
|
|
8,138
|
|
|
|
0
|
|
|
|
62.55
|
|
|
|
3/21/2024
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
95,000
|
|
|
|
47,500
|
|
|
|
6.00
|
|
|
|
11/15/2030
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
5,000
|
|
|
|
3,125
|
|
|
|
11.50
|
|
|
|
01/02/2031
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Gerald Bernstein
|
|
|
2,483
|
|
|
|
2,483
|
|
|
|
40.94
|
|
|
|
1/11/2022
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
29,000
|
|
|
|
14,500
|
|
|
|
6.00
|
|
|
|
11/15/2025
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
1,000
|
|
|
|
625
|
|
|
|
11.50
|
|
|
|
01/02/2026
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Glenn Kennedy
|
|
|
2,207
|
|
|
|
0
|
|
|
|
40.38
|
|
|
|
1/22/2022
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
||||
|
|
|
|
4,000
|
|
|
|
2,000
|
|
|
|
6.00
|
|
|
|
11/15/2025
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
||||
|
|
|
|
6,000
|
|
|
|
3,750
|
|
|
|
11.50
|
|
|
|
02/17/2026
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Stephen Ospalak
|
|
|
1,379
|
|
|
|
0
|
|
|
|
78.47
|
|
|
|
7/22/2024
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
1,724
|
|
|
|
0
|
|
|
|
56.86
|
|
|
|
12/24/2023
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
20,000
|
|
|
|
10,000
|
|
|
|
6.00
|
|
|
|
11/15/2025
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Gidi Bracha
|
|
|
1,379
|
|
|
|
0
|
|
|
|
78.47
|
|
|
|
7/24/2022
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
2,483
|
|
|
|
0
|
|
|
|
62.55
|
|
|
|
3/21/2024
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
20,000
|
|
|
|
10,000
|
|
|
|
6.00
|
|
|
|
11/15/2025
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Brian Budd
|
|
|
690
|
|
|
|
0
|
|
|
|
78.47
|
|
|
|
02/18/2022
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
1,724
|
|
|
|
0
|
|
|
|
56.86
|
|
|
|
02/18/2022
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
20,000
|
|
|
|
0
|
|
|
|
6.00
|
|
|
|
02/18/2022
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Michael Kron
|
|
|
1,379
|
|
|
|
0
|
|
|
|
78.47
|
|
|
|
7/24/2022
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
||||
|
|
|
|
1,724
|
|
|
|
0
|
|
|
|
56.86
|
|
|
|
12/24/2023
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
20,000
|
|
|
|
10,000
|
|
|
|
6.00
|
|
|
|
11/15/2025
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
Peter Goldstein
|
|
|
20,000
|
|
|
|
10,000
|
|
|
|
6.00
|
|
|
|
11/15/2025
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
||||
|
Luisa Ingargiola
|
|
|
10,000
|
|
|
|
0
|
|
|
|
11.50
|
|
|
|
10/29/2022
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
||||
|
Lourdes Felix
|
|
|
20,000
|
|
|
|
17,500
|
|
|
|
4.00
|
|
|
|
10/29/2026
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
| 67 |
| 68 |
| 69 |
|
Name
|
|
Salary
|
|
|
Bonus
|
|
|
Option Awards
|
|
|
|
Total
|
|
|||
|
USD
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Steve Ospalak
|
|
$
|
37,084
|
|
|
$
|
7,500
|
|
|
$
|
60,212
|
|
|
$
|
104,795
|
|
|
Brian Budd*
|
|
$
|
8,382
|
|
|
$
|
45,500
|
|
|
$
|
60,212
|
|
|
$
|
68,593
|
|
|
Michael Kron
|
|
$
|
52,333
|
|
|
$
|
7,500
|
|
|
$
|
60,212
|
|
|
$
|
120,044
|
|
|
Peter Goldstein
|
|
$
|
42,000
|
|
|
$
|
7,500
|
|
|
$
|
60,212
|
|
|
$
|
109,711
|
|
|
Luisa Ingargiola**
|
|
$
|
34,374
|
|
|
$
|
-
|
|
|
$
|
139,385
|
|
|
$
|
173,759
|
|
|
Lourdes Felix***
|
|
$
|
7,200
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
7,200
|
|
|
Total
|
|
$
|
181,373
|
|
|
$
|
68,000
|
|
|
$
|
380,232
|
|
|
$
|
629,605
|
|
|
*
|
Brian Budd was not re-nominated at our annual shareholders meeting.
|
|
**
|
Luisa Ingargiola was nominated to the board of directors as of February 18, 2021 and resigned as of October 29, 2021.
|
|
***
|
Lourdes Felix was appointed to the board of directors as of October 29, 2021.
|
|
Board Practices
|
| 70 |
|
●
|
appointing the independent auditors and pre-approving all auditing and non-auditing services permitted to be performed by the independent auditors;
|
|
●
|
reviewing with the independent auditors any audit problems or difficulties and management’s response;
|
|
●
|
discussing the annual audited financial statements with management and the independent auditors;
|
|
●
|
reviewing the adequacy and effectiveness of our accounting and internal control policies and procedures and any steps taken to monitor and control major financial risk exposures;
|
|
●
|
reviewing and approving all proposed related party transactions;
|
|
●
|
meeting separately and periodically with management and the independent auditors; and
|
|
●
|
monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance.
|
|
●
|
reviewing and approving the total compensation package for our most senior executive officers;
|
|
●
|
approving and overseeing the total compensation package for our executives other than the most senior executive officers;
|
|
●
|
reviewing and recommending to the board with respect to the compensation of our directors;
|
|
●
|
reviewing periodically and approving any long-term incentive compensation or equity plans;
|
|
●
|
selecting compensation consultants, legal counsel or other advisors after taking into consideration all factors relevant to that person’s independence from management; and
|
|
●
|
reviewing programs or similar arrangements, annual bonuses, employee pension and welfare benefit plans.
|
|
●
|
identifying and recommending nominees for election or re-election to our board of directors or for appointment to fill any vacancy;
|
|
●
|
reviewing annually with our board of directors its current composition in light of the characteristics of independence, age, skills, experience and availability of service to us;
|
|
●
|
identifying and recommending to our board the directors to serve as members of committees;
|
| 71 |
|
●
|
advising the board periodically with respect to significant developments in the law and practice of corporate governance as well as our compliance with applicable laws and regulations, and making recommendations to our board of directors on all matters of corporate governance and on any corrective action to be taken; and
|
|
●
|
monitoring compliance with our code of business conduct and ethics, including reviewing the adequacy and effectiveness of our procedures to ensure proper compliance.
|
|
Employees
|
| 72 |
|
Share Ownership
|
|
Major Shareholders
|
|
|
●
|
each of our directors and executive officers; and
|
|
|
●
|
each person known to us to beneficially own more than 5% of our Common Shares on an as-converted basis.
|
|
|
|
Number of
Shares Beneficially Owned
(1)
|
|
|
Percentage of
Shares Beneficially Owned
(2)
|
|
||
|
Greater than 5% Shareholders:
|
|
|
|
|||||
|
The Phoenix Holdings Ltd.
(3)
|
|
|
650,000
|
|
|
|
12.3
|
%
|
|
Directors and Executive Officers:
|
|
|
|
|||||
|
Marc Seelenfreund
|
|
|
131,311
|
(4)(5)
|
|
|
2.5
|
%
|
|
Gerald Bernstein
|
|
|
34,978
|
(6)
|
|
|
*
|
*
|
|
Glenn Kennedy
|
|
|
8,207
|
(7)
|
|
|
*
|
|
|
Gidi Bracha
|
|
|
22,483
|
(8)
|
|
|
*
|
|
|
Brian Budd**
|
|
|
22,414
|
(9)
|
|
|
*
|
|
|
Peter Goldstein***
|
|
|
60,000
|
(10)
|
|
|
1.1
|
%
|
|
Luisa Ingargiola****
|
|
|
10,000
|
(11)
|
|
|
*
|
|
|
Stephen Ospalak
|
|
|
23,104
|
(12)
|
|
|
*
|
|
|
Michael Kron
|
|
|
24,231
|
(13)
|
|
|
*
|
|
|
Lourdes Felix*****
|
|
|
20,000
|
|
|
|
*
|
|
|
All Directors and Executive Officers as a Group (10 persons)
|
|
|
356,727
|
|
|
|
6.8
|
%
|
| 73 |
|
*
|
Less than 1%
|
|
**
|
Brian Budd was not re-nominated at our annual shareholders meeting.
|
|
***
|
Peter Goldstein became a Director effective November 1, 2020 and became Chairman of the Board of directors effective February 23, 2021.
|
|
****
|
Luisa Ingargiola became a Director effective February 23, 2021 and resigned from the Board on October 29, 2021.Prior to her resignation, 10,000 options had vested.
|
|
*****
|
Lourdes Felix became a Director effective October 29, 2021.
|
|
(1)
|
Beneficial ownership is determined in accordance with the rules of the SEC. Under these rules, a person is deemed to be a beneficial owner of a security if that person, even if not the record owner, has or shares the underlying benefits of ownership. These benefits include the power to direct the voting or the disposition of the securities or to receive the economic benefit of ownership of the securities. A person also is considered to be the “beneficial owner” of securities that the person has the right to acquire within 60 days by option or other agreement. Beneficial owners include persons who hold their securities through one or more trustees, brokers, agents, legal representatives or other intermediaries, or through companies in which they have a “controlling interest,” which means the direct or indirect power to direct the management and policies of the entity.
|
|
(2)
|
The percentages shown are based on 5,276,695 common shares issued and outstanding as of December 31, 2021.
|
|
(3)
|
The beneficial ownership is based on the latest available filing made with the SEC on Schedule 13G on February 10, 2021 and consists of 650,000 common shares. The common shares are reported as beneficially owned by various direct or indirect, majority or wholly-owned subsidiaries of the Phoenix Holdings Ltd. These subsidiaries manage their own funds and/or the funds of others, including for holders of exchange-traded notes or various insurance policies, members of pension or provident funds, unit holders of mutual funds, and portfolio management clients. Each of the subsidiaries operates under independent management and makes its own independent voting and investment decisions. The address of the holder is c/o Phoenix Holdings Ltd., Derech Hashalom 53, Givataim, 53454, Israel.
|
|
(4)
|
Accel is the holder of 23,173 common shares of which Mr. Seelenfreund receives a pecuniary interest. Accel Telecom Ltd. retains full ability to vote and dispose on such shares.
|
|
(5)
|
Represents 108,138 options convertible to Common Shares held by Mr. Seelenfreund.
|
|
(6)
|
Represents 34,966 options convertible to Common Shares held by Mr. Bernstein plus 12 common shares.
|
|
(7)
|
Represents 8,207 options convertible to Common Shares held by Mr. Kennedy.
|
|
(8)
|
Represents 22,482 options convertible to Common shares held by Gidi Bracha.
|
|
(9)
|
Represents 22,414 options convertible to Common Shares held by Mr. Budd.
|
|
(10)
|
Represents 20,000 options convertible to Common shares held by Peter Goldstein as well 40,000 common shares that is held by a Company under his control.
|
|
(11)
|
Represents 20,000 options convertible to Common shares held by Luisa Ingargiola.
|
|
(12)
|
Represents 23,103 options convertible to Common Shares held by Mr. Ospalak as well as 1 share.
|
|
(13)
|
Includes 23,103 options convertible to Common Shares held by Mr. Kron as well as 1,128 common shares.
|
| 74 |
|
Related Party Transactions
|
| 75 |
|
Interests of Experts and Counsel
|
|
Consolidated Statements and Other Financial Information
|
|
|
(a)
|
the directors may declare dividends or distributions out of our funds which are lawfully available for that purpose; and
|
|
|
(b)
|
our shareholders may, by ordinary resolution, declare dividends but no such dividend shall exceed the amount recommended by the directors.
|
| 76 |
|
Significant Changes
|
|
Offer and Listing Details
|
|
Plan of Distribution
|
|
Markets
|
|
Selling Shareholders
|
|
Dilution
|
|
Expenses of the Issue
|
|
Share Capital
|
|
Memorandum and Articles of Association
|
|
Material Contracts
|
| 77 |
|
●
|
|
●
|
|
●
|
|
●
|
|
●
|
|
●
|
|
●
|
|
●
|
|
●
|
|
Exchange Controls
|
|
Taxation
|
| 78 |
| 79 |
| 80 |
|
(i)
|
in the case of the Common Shares, the Common Shares are listed on a “designated stock exchange” as defined in the Tax Act (which currently includes the Nasdaq) or the Company qualifies as a “public corporation” (as defined in the Tax Act); and
|
|
|
|
|
|
|
(ii)
|
in the case of the Warrants,
|
|
|
|
|
|
|
a.
|
the Warrants are listed on a “designated stock exchange” as defined in the Tax Act; or
|
|
b.
|
the Warrant Shares are qualified investments as described in (i) above and neither the Company, nor any person with whom the Company does not deals at arm’s length, is an annuitant, a beneficiary, an employer or a subscriber under or a holder of such Registered Plan or DPSP.
|
| 81 |
| 82 |
| 83 |
|
●
|
75% or more of our gross income (including our pro rata share of gross income for any company, in which we are considered to own 25% or more of the shares by value), in a taxable year is passive; or
|
|
●
|
At least 50% of our assets, averaged over the year and generally determined based upon fair market value (including our pro rata share of the assets of any company in which we are considered to own 25% or more of the shares by value) are held for the production of, or produce, passive income.
|
| 84 |
|
Dividends and Paying Agents
|
|
Statement by Experts
|
|
Documents on Display
|
| 85 |
|
Subsidiary Information.
|
| 86 |
|
Debt Securities
|
|
Dec 23/21
|
|
|
June 23/21
|
|
|
Dec 28/20
|
|
|
Nov 2/23
|
|
|
|||||||||
|
$CAD7.866M
M |
|
|
$CAD1.58M
M |
|
|
$CAD
4.6MM |
|
|
$6.0MM
USD |
|
|
Total
|
|
|||||||
|
Balance December 31, 2019
|
|
|
4,049,349
|
|
|
|
0
|
|
|
|
1,047,661
|
|
|
|
-
|
|
|
|
5,097,010
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and accretion expense
|
|
|
1,536,081
|
|
|
|
91,149
|
|
|
|
116,890
|
|
|
|
-
|
|
|
|
1,744,120
|
|
|
Interest paid or accrued
|
|
|
(715,763
|
)
|
|
|
(58,889
|
)
|
|
|
(56,551
|
)
|
|
|
-
|
|
|
|
(831,203
|
)
|
|
Rollover to the 10% convertible debenture
|
|
|
-
|
|
|
|
-
|
|
|
|
(186,359
|
)
|
|
|
-
|
|
|
|
(186,359
|
)
|
|
Issuance of the 10% convertible debenture
|
|
|
-
|
|
|
|
1,113,657
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,113,657
|
|
|
Repayment of 10.5% convertible debenture
|
|
|
-
|
|
|
|
-
|
|
|
|
(890,794
|
)
|
|
|
-
|
|
|
|
(890,794
|
)
|
|
Foreign exchange adjustment
|
|
|
186,165
|
|
|
|
-
|
|
|
|
(30,847
|
)
|
|
|
-
|
|
|
|
155,318
|
|
|
Convert $75,000 debentures into share capital
|
|
|
(40,980
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(40,980
|
)
|
|
Balance December 31, 2020
|
|
|
5,014,852
|
|
|
|
1,145,917
|
|
|
|
-
|
|
|
|
-
|
|
|
|
6,160,769
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest and accretion expense
|
|
|
1,893,494
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
1,893,494
|
|
|
Interest paid or accrued
|
|
|
(746,145
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(746,145
|
)
|
|
Issuance of the $6MM debenture
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
4,395,881
|
|
|
|
4,395,881
|
|
|
Repayment of 10% convertible debenture
|
|
|
-
|
|
|
|
(1,145,917
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
(1,145,917
|
)
|
|
Repayment of the 12% debenture
|
|
|
(6,162,201
|
)
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
(6,162,201
|
)
|
|
Unamortized fair value difference-opening
|
|
|
-
|
|
|
|
(1,341,948
|
)
|
|
|
(1,341,948
|
)
|
||||||||
|
Amortization of fair value difference
|
|
|
111,830
|
|
|
|
111,830
|
|
||||||||||||
|
Change in fair value of debenture
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
177,530
|
|
|
|
177,530
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance Dec 31, 2021
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
3,343,293
|
|
|
|
3,343,293
|
|
|
Current portion of debenture
|
|
|
(1,421,911
|
)
|
|
|
(1,421,911
|
)
|
||||||||||||
|
Long term portion of debenture
|
|
|
1,921,382
|
|
|
|
1,921,382
|
|
||||||||||||
| 87 |
| 88 |
| 89 |
|
Balance, December 31, 2020
|
|
$
|
-
|
|
|
Fair value difference on issuance
|
|
|
1,341,948
|
|
|
Recognized in profit or loss
|
|
|
-111,830
|
|
|
Balance, December 31, 2021
|
|
$
|
1,230,118
|
|
|
Promissory
Note |
|
|||
|
Balance, December 31, 2020
|
|
$
|
-
|
|
|
Fair value on initial recognition
|
|
|
4,395,881
|
|
|
Change in fair value
|
|
|
177,530
|
|
|
Unamortized day one fair value difference
|
|
|
-1,230,118
|
|
|
Balance, December 31, 2021
|
|
$
|
3,343,293
|
|
|
Current position
|
|
|
-1,421,911
|
|
|
Long term position
|
|
$
|
1,921,382
|
|
|
`
|
Subsequent to year-end, the Company completed a secondary offering of its common shares at a price of $2.30 per common share. In accordance with the terms of the agreement, as the common shares of the secondary prices were offered at a price less than the stated Conversion Price (US$10.00 per common share) of the promissory note and the Exercise Price of the warrants (US$4.00 per common share), both the Conversion Price and the Exercise Price were revised to US$2.30 per common share. In addition, as the total gross proceeds of the secondary offering were in excess of $10,000,000, excluding offering costs or other expenses, the Company was required to direct 20% of the gross proceeds to the Lender. A total of US$4,000,000 was repaid to the Lender on January 13, 2022.
|
| 90 |
|
Warrants and Rights
|
|
Warrant liability
|
|
|||
|
Balance, December 31, 2020
|
|
$
|
-
|
|
|
Warrants issued as part of the convertible promissory note
|
|
|
2,946,066
|
|
|
Impact of warrants exercised during the year
|
|
|
(385,190
|
)
|
|
Change in fair value
|
|
|
(384,190
|
)
|
|
Balance, December 31, 2021
|
|
$
|
2,176,686
|
|
|
Other Securities
|
|
American Depositary Shares
|
| 91 |
|
Use of Proceeds
|
| 92 |
| 93 |
| 94 |
|
|
|
Year Ended
December 31, |
|
|||||
|
|
|
2021
|
|
|
2020
|
|
||
|
Audit fees (1)
|
|
$
|
192,242
|
|
|
$
|
107,692
|
|
|
Audit-related fees
|
|
$
|
56,000
|
|
|
$
|
90,385
|
|
|
Tax fees (2)
|
|
$
|
12,163
|
|
|
$
|
9,808
|
|
|
All other fees
|
|
$
|
0
|
|
|
$
|
3,462
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
260,405
|
|
|
$
|
211,347
|
|
|
(1)
|
Includes professional services rendered in connection with the audit of our annual financial statements, review of our interim financial statements, and fees relating to fundraising.
|
|
(2)
|
Tax fees are the aggregate fees billed (in the year) for professional services rendered for tax compliance and tax advice other than in connection with the audit.
|
| 95 |
|
●
|
Distribution of periodic reports to shareholders; proxy solicitation.
As opposed to the Nasdaq Stock Market rules, which require listed issuers to make such reports available to shareholders in one of a number of specific manners, our home country rules do not require us to distribute periodic reports directly to shareholders, and the generally accepted business practice is not to distribute such reports to shareholders but to make such reports available through a public website. In addition to making such reports available on a public website, we currently make our audited financial statements available to our shareholders at our offices and will only mail such reports to shareholders upon request. As a foreign private issuer, we are generally exempt from the SEC’s proxy solicitation rules.
|
|
●
|
Quorum
. While the Nasdaq Stock Market rules require that the quorum for purposes of any meeting of the holders of a listed company’s common voting stock, as specified in a company’s bylaws, be no less than 33 1/3% of the company’s outstanding common voting stock, under our home country rules, a company is entitled to determine in its articles of association the number of shareholders and percentage of holdings required for a quorum at a shareholders meeting. Our articles of association provide that a quorum of two or more shareholders who are, or represent by proxy, shareholders holding, in the aggregate, at least 33.33% of the issued shares entitled to be voted at the meeting. However, the quorum set forth in our articles of association with respect to an adjourned meeting consists of one or more shareholders entitled to attend and vote at the meeting if the standard required quorum is not present within half an hour from the time set for the holding of such adjourned meeting.
|
|
●
|
Majority Independent Directors
. The corporate governance practice in our home country does not require a majority of our board to consist of independent directors. Thus, although a director must act in the best interests of the Company, it is possible that fewer board members will be exercising independent judgment and the level of board oversight on the management of our company may decrease as a result. Currently, however, our board of consists of a majority of independent directors.
|
| 96 |
|
Exhibit
|
|
Description
|
|
|
||
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
|
||
|
|
|
|
|
101**
|
|
The following financial information from the Registrant’s Annual Report on Form 20-F for the year ended December 31, 2021, formatted in XBRL (eXtensible Business Reporting Language): (i) Consolidated Balance Sheet, (ii) Consolidated Statements of Operations and Comprehensive Income; (iii) Consolidated Statements of Changes in Stockholders’ Deficit; (iv) Consolidated Statements of Cash Flows; and (v) Notes to Consolidated Financial Statements, tagged as blocks of text and in detail.
|
|
*
|
filed herewith.
|
|
**
|
furnished herewith.
|
| 97 |
|
|
SIYATA MOBILE INC.
|
|
|
|
|
|
|
Date: April __, 2022
|
By:
|
/s/ Marc Seelenfreund
|
|
|
|
Marc Seelenfreund
|
|
|
|
Chief Executive Officer
|
| 98 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| F-1 |
| F-2 |
|
|
December 31 2021
|
|
|
December 31 2020
|
|
|||
| ASSETS | ||||||||
| Current | ||||||||
| Cash |
|
|
||||||
| Restricted cash (Note 5) | - |
|
||||||
| Trade and Other Receivables (Note 6) |
|
|
||||||
| Prepaid expenses |
|
|
||||||
| Inventory (Note 7) |
|
|
||||||
| Advance to suppliers |
|
|
||||||
|
|
|
|||||||
|
Long term
receivable
(note 13)
|
|
|
|
|
|
|
-
|
|
| Right of Use Assets Note 8) |
|
|
||||||
| Loan to Director (Note 9) | - |
|
||||||
| Equipment |
|
|
||||||
| Intangible assets (Note 10) |
|
|
||||||
| Goodwill (Note 11) | - |
|
||||||
| Total assets |
|
|
||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||
| Current | ||||||||
| Bank Loan (Note 12) |
|
|
||||||
| Accounts payable and accrued liabilities |
|
|
||||||
| Lease Obligations (Note 13) |
|
|
||||||
| Convertible debenture (Note 14) |
|
|
||||||
| Warrant liability (note 15) |
|
- | ||||||
| Current portion of long term debt (Note 16) | - |
|
||||||
| Future Purchase Consideration (Note 4,17) |
|
- | ||||||
|
|
|
|||||||
| Lease Obligation (Note 13) |
|
|
||||||
| Other payables | - |
|
||||||
| Convertible debenture (Note 14) |
|
- | ||||||
| Long Term Debt (Note 16) | - |
|
||||||
|
|
|
|||||||
| Total Liabilities |
|
|
||||||
| Shareholders' equity | ||||||||
| Share capital (Note 18) |
|
|
||||||
| Reserves (Note 18) |
|
|
||||||
| Accumulated other comprehensive loss |
(
|
) |
|
|||||
| Deficit |
(
|
) |
(
|
) | ||||
| Shareholders' equity |
|
|
||||||
| Total liabilities and shareholders' equity |
|
|
||||||
|
“Michael Kron”
|
“Marc Seelenfreund“
|
|
|
Michael Kron – Director
|
Marc Seelenfreund - Director
|
| F-3 |
|
|
2021
|
|
|
2020
|
|
|
2019
|
|
||||
| Revenue |
|
|
|
|
|
|
||||||
| Cost of Sales (Note 19) |
|
|
(
|
)
|
(
|
) |
(
|
) | ||||
|
Gross profit
|
|
|
|
|
|
|
||||||
|
EXPENSES
|
||||||||||||
| Amortization and Depreciation (Note 10) |
|
|
|
|
|
|
||||||
| Development expenses (Note 10) |
|
|
|
|
|
|
||||||
| Selling and marketing (Note 20) |
|
|
|
|
|
|
||||||
| General and administrative (Note 21) |
|
|
|
|
|
|
||||||
| Inventory impairment (Note 7) |
|
|
|
|
|
|
||||||
| Bad Debts (recovered) (Note 6) |
|
|
|
|
|
- | ||||||
| Impairment of intangibles (Note 10) |
|
|
|
|
|
|
||||||
| Impairment goodwill (Note 11) |
|
|
|
|
- | - | ||||||
| Share-based payments (Note 18) |
|
|
|
|
|
|
||||||
| Total Operating Expenses |
|
|
|
|
|
|
||||||
|
Net operating loss
|
|
|
(
|
)
|
(
|
) |
(
|
) | ||||
|
OTHER EXPENSES
|
|
|||||||||||
| Finance expense (income) (note 22) |
|
|
|
|
|
|
||||||
| Foreign exchange |
|
|
|
|
(
|
) |
|
|||||
| Change in fair value of convertible promissory note |
|
|
|
|
- | - | ||||||
| Change in fair value of warrant liability |
|
|
(
|
)
|
- | - | ||||||
|
A
c
cretion and change in value of future
purchase
consideration
|
|
|
-
|
|
- |
|
||||||
| Transaction costs (Note 23) |
|
|
|
|
|
- | ||||||
|
Total other expenses
|
|
|
|
|
|
|
||||||
|
Net loss for the year
|
|
|
(
|
)
|
(
|
) |
(
|
) | ||||
|
Other comprehensive income
|
||||||||||||
| Translation Adjustment |
|
|
|
|
|
(
|
) | |||||
|
Comprehensive loss for the year
|
|
|
(
|
)
|
(
|
) |
(
|
) | ||||
| Weighted Average Shares |
|
|
|
|
|
|
||||||
| Basic and diluted loss per share |
|
|
(
|
)
|
(
|
) |
(
|
) | ||||
| F-4 |
|
|
Number of Common Shares
|
|
|
Share Capital Amount
|
|
|
Reserves
|
|
|
Accumulated other comprehensive Income (loss)
|
|
|
Deficit
|
|
|
Total Shareholders’ Equity
|
|
|||||||
|
Balance, December 31, 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
$
|
|
|
| Exercise of Warrants |
|
|
- | - | - |
|
||||||||||||||||||
| Shares issued on acquisition of Signifi |
|
|
- | - | - |
|
||||||||||||||||||
| Exercise of agents’ options |
|
|
(
|
) | - | - |
|
|||||||||||||||||
| Non-brokered private placement |
|
|
- | - | - |
|
||||||||||||||||||
| Share Issuance costs on capital raise |
-
|
(
|
) |
-
|
- |
-
|
(
|
) | ||||||||||||||||
| Shares issued as agent compensation for debenture |
|
|
- | - | - |
|
||||||||||||||||||
| Expiry of agent’s options | - |
|
(
|
) | - | - | - | |||||||||||||||||
| Equity portion of the debenture bifurcated | - | - |
|
- | - |
|
||||||||||||||||||
| Issuance of agents’ warrants | - | - |
|
- | - |
|
||||||||||||||||||
| Issuance of warrants to debentureholders | - | - |
|
- | - |
|
||||||||||||||||||
| Share based payments | - | - |
|
- | - |
|
||||||||||||||||||
| Translation adjustment | - | - | - |
(
|
) |
|
(
|
) | ||||||||||||||||
| Loss for the period | - | - | - | - |
(
|
) |
(
|
) | ||||||||||||||||
|
Balance, December 31, 2019
|
|
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
($
|
|
)
|
|
$
|
|
|
| Equity portion of debenture bifurcated | - | - |
|
- | - |
|
||||||||||||||||||
| Share based payments | - | - |
|
- | - |
|
||||||||||||||||||
| Share issuance on conversion of convertible debt |
|
|
|
- | - |
|
||||||||||||||||||
| Share issuance on capital raise |
|
|
|
-
|
-
|
|
||||||||||||||||||
| Share issuance costs on capital raise |
-
|
(
|
) |
|
-
|
-
|
(
|
) | ||||||||||||||||
| shares issued for debt |
|
|
-
|
-
|
|
|||||||||||||||||||
| Translation adjustment |
-
|
- | - |
|
- |
|
||||||||||||||||||
| Loss for the period |
-
|
- | - |
|
|
-
|
|
(
|
) |
(
|
) | |||||||||||||
|
Balance, December 31, 2020
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
($
|
|
)
|
|
$
|
|
|
|||
| Issuance of shares to be issued |
|
|
(
|
) | - | - | - | |||||||||||||||||
| Shares issued on acquisition of ClearRF |
|
|
- | - | - |
|
||||||||||||||||||
| Shares issued on warrant exercises |
|
|
(
|
) | - | - |
|
|||||||||||||||||
| Share based payments | - | - |
|
- | - |
|
||||||||||||||||||
| Translation adjustment | - | - | - |
(
|
) | - |
(
|
) | ||||||||||||||||
|
Shares
issued
for debts
|
|
|
-
|
-
|
-
|
|
||||||||||||||||||
| Loss for the period | - | - | - |
-
|
(
|
) |
(
|
) | ||||||||||||||||
|
Balance, December 31, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
| F-5 |
|
2021
|
|
|
2020
|
|
|
2019
|
|
|||||
|
Operating activities:
|
|
|
||||||||||
|
Net loss for the period
|
|
($
|
|
)
|
|
($
|
|
)
|
|
($
|
|
)
|
|
Items not affecting cash:
|
|
|
||||||||||
|
Amortization and depreciation
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bad debt expense
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
Inventory impairments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangible impairment
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impairment goodwill
|
|
|
|
|
|
|
-
|
|
|
|
-
|
|
|
Fair value changes on derivatives
|
|
|
(
|
)
|
|
|
-
|
|
|
|
-
|
|
|
Interest expense, net of repayments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
-
|
|
|
|
(
|
)
|
|
|
-
|
|
|
Foreign exchange
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
Share-based payments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss on debt conversion
|
|
|
-
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
||||||||||
|
Net change in non-cash working capital items:
|
|
|
||||||||||
|
Trade and other receivables
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Prepaids
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
Inventory
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
Advances to suppliers
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Accounts payable and accrued liabilities
|
|
|
(
|
)
|
|
|
|
|
|
|
(
|
)
|
|
Due to/from related party
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Net cash used in operating activities
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Investing activities:
|
|
|
||||||||||
|
Intangible additions
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Equipment additions
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
-
|
|
|
Acquistion of ClearRF
|
|
|
(
|
)
|
|
|
-
|
|
|
|
-
|
|
|
Net cash used in investing activities
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Financing activities:
|
|
|
||||||||||
|
Lease payments
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Bank loan
|
|
|
(
|
)
|
|
|
|
|
|
|
(
|
)
|
|
Repayment of long term debt
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Convertible debt issued, net of repayments
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
Shares issued for cash
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Share issue costs (cash)
|
|
|
-
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Loan to director
|
|
|
-
|
|
|
|
(
|
)
|
||||
|
Exercise of agent's options
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
Exercise of warrants
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
Loan received
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
Net cash from financing activities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effect of foreign exchange on cash
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
|
|
|
Change in cash for the period
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
Cash and restricted cash, beginning of year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and restricted cash, end of year
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
| F-6 |
|
NATURE OF OPERATIONS AND GOING CONCERN
|
|
2.
|
BASIS OF PREPARATION
|
| F-7 |
|
2.
|
BASIS OF PREPARATION
(cont’d)
|
|
Name of Subsidiary
|
Place of Incorporation
|
Ownership
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
||
|
|
|
|
| F-8 |
|
2
.
|
BASIS OF PREPARATION
(cont’d)
|
|
i)
|
Critical accounting estimates
|
|
·
|
Income taxes - Tax provisions are based on enacted or substantively enacted laws. Changes in those laws could affect amounts recognized in profit or loss both in the period of change, which would include any impact on cumulative provisions, and future periods. Deferred tax assets, if any, are recognized to the extent it is considered probable that those assets will be recoverable. This involves an assessment of when those deferred tax assets are likely to reverse.
|
| F-9 |
|
2
.
|
BASIS OF PREPARATION
(cont’d)
|
|
·
|
Fair value measurements - Certain of the Company’s (financial) assets and liabilities are measured at fair value. In estimating fair value, the Company uses market-observable data to the extent it is available. In certain cases where Level 1 inputs are not available the Company will engage third-party qualified valuators to perform the valuation. Information about the valuation techniques and inputs used in determining the fair value of financial instruments is in Note 14(e).
|
|
·
|
Fair value of stock options and warrants - Determining the fair value of warrants and stock options requires judgments related to the choice of a pricing model, the estimation of stock price volatility, the expected forfeiture rate and the expected term of the underlying instruments. Any changes in the estimates or inputs utilized to determine fair value could have a significant impact on the Company’s future operating results or on other components of shareholders’ equity.
|
|
·
|
Capitalization of development costs and their amortization rate – Development costs are capitalized in accordance with the accounting policy. To determine the amounts earmarked for capitalization, management estimates the cash flows which are expected to be derived from the asset for which the development is carried out and the expected benefit period.
|
|
·
|
Inventory - Inventory is valued at the lower of cost and net realizable value. Cost of inventory includes cost of purchase (purchase price, import duties, transport, handling, and other costs directly attributable to the acquisition of inventories), cost of conversion, and other costs incurred in bringing the inventories to their present location and condition. Net realizable value for inventories is the estimated selling price in the ordinary course of business less the estimated costs of completion and the estimated costs necessary to make the sale. Provisions are made in profit or loss of the current period on any difference between book value and net realizable value.
|
|
·
|
Estimated product returns - Revenue from product sales is recognized net of estimated sales discounts, credits, returns, rebates and allowances. The return allowance is determined based on an analysis of the historical rate of returns, industry return data, and current market conditions, which is applied directly against sales.
|
|
·
|
Impairment of non-financial assets - The Company assesses impairment at each reporting date by evaluating conditions specific to the Company that may lead to asset impairment. The recoverable amount of an asset or a cash-generating unit (“CGU”) is determined using the greater of fair value less costs to sell and value in use which requires the use of various judgments, estimates, and assumptions. The Company identifies CGUs as identifiable groups of assets that are largely independent of the cash inflows from other assets or groups of assets. Value in use calculations require estimations of discount rates and future cash flows derived from revenue growth, gross margin and operating costs. Fair value less costs to sell calculations require the Company to estimate fair value of an asset or a CGU using market values of similar assets as well as estimations of the related costs to sell.
|
|
·
|
Useful life of intangible assets – The Company estimates the useful life used to amortize intangible assets which relates to the expected future performance of the assets acquired based on management estimate of the sales forecast.
|
|
·
|
Collectability of trade receivables – In order for management to determine expected credit losses in accordance with IFRS 9, we are required to make estimates based on historical information related to collections, in addition to taking the current condition of our customers credit quality into account.
|
| F-10 |
|
2.
|
BASIS OF PREPARATION
(cont’d)
|
|
ii)
|
Critical accounting judgments
|
|
·
|
Deferred income taxes – judgments are made by management to determine the likelihood of whether deferred income tax assets at the end of the reporting period will be realized from future taxable earnings. To the extent that assumptions regarding future profitability change, there can be an increase or decrease in the amounts recognized in respect of deferred tax assets as well as the amounts recognized in profit or loss in the period in which the change occurs.
|
|
·
|
Functional currency - The functional currency for the Company and each of its subsidiaries is the currency of the primary economic environment in which the respective entity operates. The Company has determined the functional currency of each entity to be the USD as of October 1, 2020, except for Signifi Mobile Inc. whose functional currency is Canadian dollars. The Company reconsiders the functional currency of its subsidiaries if there is a change in events and/or conditions that determine the primary economic environment.
|
|
·
|
Going concern – As disclosed in Note 1 to the consolidated financial statements.
|
|
3.
|
SIGNIFICANT ACCOUNTING POLICIES
|
|
(a)
|
Impairment of long lived assets
|
| F-11 |
|
3.
|
SIGNIFICANT ACCOUNTING POLICIES (Cont’d)
|
|
(b)
|
Intangible assets
|
| i) | Research and development |
| ii) | Subsequent expenditure |
| iii) | Amortization |
|
(c)
|
Business Combinations
|
| F-12 |
|
3.
|
SIGNIFICANT ACCOUNTING POLICIES (Cont’d)
|
|
(d)
|
Goodwill
|
|
(e)
|
Inventory
|
|
(f)
|
Revenues
|
|
(g)
|
Financial Instruments
|
| F-13 |
|
3.
|
SIGNIFICANT ACCOUNTING POLICIES (Cont’d)
|
|
(g)
|
Financial Instruments (cont’d)
|
| F-14 |
|
3.
|
SIGNIFICANT ACCOUNTING POLICIES (Cont’d)
|
|
(h)
|
Loss per share
|
|
(i)
|
Share-based payments
|
|
(j)
|
Income taxes
|
| F-15 |
|
3.
|
SIGNIFICANT ACCOUNTING POLICIES (Cont’d)
|
|
(k)
|
Leases
|
|
(l)
|
Equipment
|
|
(m)
|
New accounting pronouncements
|
| F-16 |
|
4.
|
ACQUISITION OF CLEAR RF LLC
|
| a) |
On March 31, 2022, pay $
|
| b) |
On March 31, 2022, issue common shares of the Company valued at $
|
| c) | In addition to the above, further incentives may be earned and payable to the vendors based on revenues earned from the date of acquisition to March 31, 2022, inclusive. |
| Consideration | Note | Fair Value | ||||||
| Cash | $ |
|
||||||
|
Fair value of
|
(i)
|
|
||||||
| Future purchase consideration |
(ii)
|
|
||||||
| Total Consideration | $ |
|
||||||
|
(i)
|
The fair value of the shares issued was determined by multiplying the number shares issued by the share price of the Company on March 31, 2021. |
|
(ii)
|
Future consideration represents the expected future payments of cash and common shares. Since the balance of the shares and the cash is due within one year, the Company did not discount the future purchase consideration for the time value of money. |
| Purchase price allocation | Fair Value | |||
| Purchase price | $ |
|
||
| Less: Net assets acquired | ||||
| Net identifiable tangible assets |
|
|||
| Net identifiable intangible assets |
|
|||
|
|
||||
| Goodwill | $ |
|
||
| F-17 |
|
4.
|
ACQUISITION OF CLEAR RF LLC (CONT’d)
|
|
5.
|
RESTRICTED CASH
|
|
6.
|
TRADE AND OTHER RECEIVABLES
|
|
|
31-Dec-21
|
|
|
31-Dec-20
|
|
|||
| Trade receivables | $ |
|
$ |
|
||||
| Allowance for doubtful accounts |
(
|
) |
(
|
) | ||||
| Taxes receivable |
|
|
||||||
|
Total
|
|
$
|
|
|
|
$
|
|
|
| F-18 |
|
7.
|
INVENTORY
|
|
|
31-Dec-21
|
|
|
31-Dec-20
|
|
|||
| Finished products |
|
|
||||||
| Impairment of finished products |
(
|
) |
(
|
) | ||||
| Accessories and spare parts |
|
|
||||||
| Impairment of accessories and spare parts |
(
|
) |
(
|
) | ||||
|
Total
|
|
$
|
|
|
|
$
|
|
|
|
8.
|
RIGHT OF USE ASSETS
|
| Dec 31 21 | Dec 31 20 | |||||||
| Opening Balance |
|
$
|
|
|
$ |
|
||
| Addition in the year |
|
|
|
|
|
|||
| Translation adjustment |
|
|
(
|
)
|
|
|||
| Amortization in the year |
|
|
(
|
)
|
(
|
) | ||
|
Closing Balance
|
|
$
|
|
|
$ |
|
||
|
Allocation of Right of Use Assets
|
||||||||
| Office lease |
|
$
|
|
|
$ |
|
||
| Car leases |
|
|
|
|
|
|||
|
Total Right of Use Assets
|
|
$
|
|
|
$ |
|
||
|
9.
|
LOAN TO DIRECTOR
|
| F-19 |
|
10.
|
INTANGIBLE ASSETS
|
|
|
Development Costs
|
|
|
Uniden License
|
|
|
E-Wave License
|
|
|
Clear RF Patent + Supplier relationship
|
|
|
Total
|
|
||||||
|
Cost:
|
||||||||||||||||||||
|
Balance at December 31, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
| Additions |
|
- | - |
-
|
|
|||||||||||||||
| Foreign Exchange |
|
|
|
-
|
|
|||||||||||||||
|
Balance at December 31, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
- |
|
|
|
|
|||
| Additions |
|
- | - |
|
|
|||||||||||||||
| Foreign Exchange | $ |
|
|
|
-
|
|
||||||||||||||
|
Balance at December 31, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated Amortization:
|
||||||||||||||||||||
|
Balance at December 31, 2019
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
| Additions |
|
|
|
|
|
|
|
|
|
-
|
|
|||||||||
| Impairment |
|
- | - |
-
|
|
|||||||||||||||
| Foreign Exchange |
|
|
|
-
|
|
|||||||||||||||
|
Balance at December 31, 2020
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
-
|
|
|
|
|
|
| Additions |
|
|
|
|
|
|||||||||||||||
| Impairment |
|
- | - |
|
|
|||||||||||||||
| Foreign Exchange |
(
|
) |
(
|
) |
(
|
) |
-
|
(
|
) | |||||||||||
|
Balance at December 31, 2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Book Value:
|
||||||||||||||||||||
| Balance at December 31, 2020 | $ |
|
$ |
|
$ |
|
|
$ |
|
|||||||||||
|
Balance at December 31, 2021
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
| F-20 |
|
10.
|
INTANGIBLE ASSETS (Cont’d)
|
| F-21 |
|
11.
|
GOODWILL
|
|
12.
|
BANK LOAN
|
| F-22 |
|
13.
|
LEASE OBLIGATIONS
|
| Dec 31 21 | Dec 31 20 | |||||||
| Opening Balance |
|
$
|
|
|
$ |
|
||
| Additions in the year |
|
|
|
|
|
|||
| Interest expense |
|
|
|
|
|
|||
| Translation adjustment |
|
|
|
|
(
|
) | ||
| Lease payments |
|
|
(
|
)
|
(
|
) | ||
|
|
|
|
|
|
||||
| Due within one year |
(
|
) |
(
|
) | ||||
|
Balance-end of period
|
|
$
|
|
|
$ |
|
||
| Dec 31 21 | Dec 31 20 | |||||||
| year 1 |
|
|
|
|
$ |
|
||
| year 2 |
|
|
|
|
|
|||
| year 3 |
|
|
|
|
|
|||
| year 4 |
|
|
|
|
|
|||
|
Tota
l
lease obligations
|
|
$
|
|
|
$ |
|
||
|
14.
|
CONVERTIBLE DEBENTURES
|
| Dec 23/21 | June 23/21 | Dec 28/20 | Nov 2/23 | |||||||||||||||||
| $7.866MM | $1.58MM | $4.6MM | $6.0MM USD | Total | ||||||||||||||||
|
Balance December 31, 2019
|
|
|
|
|
|
|||||||||||||||
| Interest and accretion expense |
|
|
|
|
|
|||||||||||||||
| Interest paid or accrued |
(
|
) |
(
|
) |
(
|
) |
|
(
|
) | |||||||||||
|
Rollover to the
|
|
|
(
|
) |
|
(
|
) | |||||||||||||
|
Issuance of the
|
|
|
|
|
|
|||||||||||||||
|
Repayment of
|
|
|
(
|
) |
|
(
|
) | |||||||||||||
| Foreign exchange adjustment |
|
|
(
|
) |
|
|
||||||||||||||
|
Convert $
|
(
|
) |
|
|
|
(
|
) | |||||||||||||
|
Balance December 31, 2020
|
|
|
|
|
|
|||||||||||||||
| Interest and accretion expense |
|
|
|
|
|
|||||||||||||||
| Interest paid or accrued |
(
|
) |
|
|
|
(
|
) | |||||||||||||
|
Issuance of the $
|
|
|
|
|
|
|||||||||||||||
|
Repayment of
|
|
(
|
) |
|
|
(
|
) | |||||||||||||
|
Repayment of the
|
(
|
) |
|
|
|
(
|
) | |||||||||||||
| Unamortized fair value difference-opening |
|
|
|
(
|
) |
(
|
) | |||||||||||||
| Amortization of fair value difference |
|
|
|
|
||||||||||||||||
| Change in fair value of debenture |
|
|
|
|
|
|||||||||||||||
|
Balance Dec 31, 2021
|
|
|
|
|
|
|||||||||||||||
| Current portion of debenture |
|
|
|
(
|
) |
(
|
) | |||||||||||||
| Long term portion of debenture |
|
|
|
|
|
|||||||||||||||
| F-23 |
|
14.
|
CONVERTIBLE DEBENTURES (CONT’D)
|
| (a) |
On December 28, 2017, the Company issued
|
| (b) |
On December 23, 2019, the Company issued
|
| F-24 |
|
14.
|
CONVERTIBLE DEBENTURES (CONT’D)
|
| (c) |
On June 23, 2020, the Company entered into a non-brokered private placement financing agreement with Accel Telecom Inc. Accel Telecom subscribed for
e
.
|
| (d) |
On June 28, 2020, one of the
|
| F-25 |
|
14.
|
CONVERTIBLE DEBENTURES (CONT’D)
|
| Balance, December 31, 2020 | $ | - | ||
| Fair value difference on issuance |
|
|||
| Recognized in profit or loss |
(
|
) | ||
| Balance, December 31, 2021 |
|
$
|
|
|
| F-26 |
|
14.
|
CONVERTIBLE DEBENTURES (CONT’D)
|
|
|
Promissory Note
|
|
||
| Balance, December 31, 2020 | $ |
|
||
| Fair value on initial recognition |
|
|||
| Change in fair value |
|
|||
| Unamortized day one fair value difference |
(
|
) | ||
| Balance, December 31, 2021 |
|
$
|
|
|
| Current portion |
|
|
(
|
)
|
| Long term portion | $ |
|
||
| F-27 |
|
15.
|
WARRANT LIABILITY
|
|
|
Warrant liability
|
|
||
| Balance, December 31, 2020 | $ |
|
||
| Warrants issued as part of the convertible promissory note |
|
|||
| Impact of warrants exercised during the year |
(
|
) | ||
| Change in fair value |
(
|
) | ||
| Balance, December 31, 2021 |
|
$
|
|
|
|
16.
|
LONG TERM DEBT
|
|
|
31-Dec-21
|
|
|
31-Dec-20
|
|
|||
|
Balance, Beginning of Year
|
|
$
|
|
|
$ |
|
||
| Foreign Exchange adjustment |
|
|
||||||
| Capital repayments in the period |
(
|
) |
(
|
) | ||||
|
|
|
|
|
|
|
|
|
|
|
Less: current portion of long term debt
|
- |
(
|
) | |||||
|
Balance, End of Year
|
|
$
|
|
|
|
$
|
|
|
| F-28 |
|
17.
|
FUTURE PURCHASE CONSIDERATION
|
|
2021
|
2020
|
|||||||
| Balance, beginning of the period | $ |
|
$ |
|
||||
| ClearRF future purchase consideration |
|
|
||||||
|
Balance, end of the period
|
|
$
|
|
|
|
$
|
|
|
| Classification: | ||||||||
| Short-term (payable within one year) | $ |
|
|
|||||
| Long-term |
|
|
||||||
|
18.
|
SHARE CAPITAL
|
|
(a)
|
Authorized
Unlimited number of common shares without par value
|
| F-29 |
|
18.
|
SHARE CAPITAL (CONT’D
)
|
|
(b)
|
Common share transactions
|
| (i) |
During the month of February 2021, the Company received multiple tradeable warrant exercises for total proceeds of $
|
| (ii) |
The company issued in February 2021, the
|
| (iii) |
As discussed in Note 4 -Acquisition of ClearRF, the Company issued
|
| (iv) |
On July 21, 2021, the Company issued
|
| (v) |
On October 28, 2021, received gross cash of $
|
| (vi) |
On December 7, 2021,
|
| (i) |
On June 22, 2020, the Company issued
|
| (ii) |
On August 4, 2020, the Company completed a two part private placement raising aggregate gross proceeds of $
|
| (iii) |
On September 29, 2020 the Company completed an initial public offering of
|
| (iv) |
During the month of November 2020, the Company issued
|
| (v) |
On December 14, 2020, the Company issued
|
| F-30 |
|
18.
|
SHARE CAPITAL (CONT’D
)
|
|
(b)
|
Common share transactions (cont’d)
|
| (vi) |
On December 31, 2020,
|
| i) | Issued 5,668 common shares in connection with exercised of agents’ options for proceeds of $345,832. |
| ii) | Issued 80,865 common shares in connection with exercise of warrants for proceeds of $4,418,377. |
| iii) | Issued 6,897 common shares in connection with purchase consideration for Signifi with the value of the shares as $346,673. |
|
iv)
|
On August 29, 2019 the Company completed a non-brokered private placement of 51,724 units at a price of $44.29 ($58.00 CAD) per unit for gross proceeds of $2,290,916. Each unit consisted of one common share and one-half share purchase warrant. Each warrant is exercisable at a price of $68.23 ($87.00 CAD) for a period of two years. In conjunction with the placement, the Company incurred share issuance costs of $185,854. |
| F-31 |
|
18.
|
SHARE CAPITAL (CONT’D
)
|
|
(c)
|
Stock options
|
|
|
|
Number of
Stock Options |
|
|
Weighted
Average Exercise Price |
|
||
|
Outstanding options, December 31, 2018
|
|
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
|
|
Expired
|
|
|
(
|
)
|
|
|
|
|
|
Outstanding options, December 31, 2019
|
|
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
|
|
Expired/Cancelled
|
|
|
(
|
)
|
|
|
|
|
|
Outstanding options, December 31, 2020
|
|
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
|
|
Expired/Cancelled
|
|
|
(
|
)
|
|
|
|
|
|
Outstanding options, December 31, 2021
|
|
|
|
|
|
$
|
|
|
| F-32 |
|
18.
|
SHARE CAPITAL (CONT’D
)
|
|
(
c)
|
Stock options (cont’d)
|
|
Grant Date
|
|
Number of
options outstanding |
|
Number of
options exercisable |
|
Weighted
Average Exercise Price |
|
Expiry date
|
|
Remaining contractual
life (years) |
|
||||
|
|
|
|
$ |
|
|
|
* | ||||||||
|
|
|
|
|
|
|
* | |||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
* | |||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
* | |||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
* | |||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
|
|
|
|
|
|
||||||||||
|
Total
|
|
|
|
|
|
|
|
$
|
|
|
|
|
|
||
| F-33 |
|
18.
|
SHARE CAPITAL (CONT’D
)
|
|
(
c
)
|
Stock options (cont’d)
|
| F-34 |
|
18.
|
SHARE CAPITAL (CONT’D
)
|
|
(
c
)
|
Stock options (cont’d)
|
|
|
2021
|
|
|
2020
|
|
|
2019
|
|
||||
| Exercise price | $ |
|
$ |
|
$ |
|
||||||
| Risk-free interest rate |
|
% |
|
% |
|
% | ||||||
| Expected life |
|
|
|
|||||||||
| Annualized volatility |
|
% |
|
% |
|
% | ||||||
| Dividend rate |
|
% |
|
% |
|
% | ||||||
|
(d)
|
Agents’ options:
|
| F-35 |
|
18.
|
SHARE CAPITAL (CONT’D
)
|
|
(d)
|
Agents’ options (cont’d)
|
|
Number of
options |
Weighted
average exercise price |
|||||||
|
Outstanding agent options, December 31, 2018
|
|
$ |
|
|||||
| Granted |
|
|
||||||
| Exercised |
(
|
) |
|
|||||
| Expired |
(
|
) |
|
|||||
|
Outstanding agent options, December 31, 2019
|
|
|
|
|
|
$
|
|
|
| Granted |
|
|
||||||
|
Outstanding agent options, December 31, 2020
|
|
|
|
|
|
|
|
|
| Expired |
(
|
) |
|
|||||
|
Outstanding agent options, December 31, 2021
|
|
|
|
|
$
|
|
|
|
|
Grant Date
|
|
Number of
options outstanding |
|
|
Number of
options exercisable |
|
|
Weighted
Average Exercise Price |
|
|
Expiry date
|
|
Remaining
contractual life (years) |
|
||||
|
|
|
|
$ |
|
|
|
||||||||||||
|
|
|
|
$ |
|
|
|
||||||||||||
|
|
|
|
$ |
|
|
|
||||||||||||
|
|
|
|
$ |
|
|
|
||||||||||||
|
Total
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
| F-36 |
|
18.
|
SHARE CAPITAL (CONT’D
)
|
|
(e)
|
Share purchase warrants
|
| a. |
During the year,
|
| b. |
In February 2021,
|
| c. |
In October 2021,
|
| d. |
On December 7, 2021,
|
| e. | See Note 15 for warrants issued in the debenture financing. These warrants have met the criteria of a liability instrument on these financial statements. |
| a) |
On June 23, 2020, as part of the
10
% convertible debenture referred to in 14(c), the Company issued
|
| b) |
On July 28, 2020, as part of the capital raise per 17(b)(ii), the Company issued
74,138
share purchase warrants at an exercise price of $
20.47
with an expiry date of July 28, 2022.
|
| c) |
On September 29, 2020, the Company issued
|
| d) | On December 31, 2020, the Company issued 1,294,500 share purchase warrants to the investors who participated in the private placement. Each unit consisted of one common share and one share purchase warrant. The warrant has an exercise price of $11.50 USD with an expiry date of June 29, 2024. |
| a. | On August 20, 2019 the Company granted 25,863 share purchase warrants as part of the unit of a private placement. These warrants have an expiry date of August 20, 2021 and an exercise price of $68.63 ($CAD87.00). |
| b. | On December 23, 2019 the Company granted 54,248 share purchase warrants as part of the unit of a debenture issue. These warrants have an expiry date of December 23, 2022 and an exercise price of $51.18 ($CAD65.25). |
| c. | Prior to their expiry on March 16, 2019, 80,865 share purchase options were exercised at $68.36 for total proceeds of $5,529,858. |
| d. | On March 16, 2019, 5,196 share purchase warrants from a private placement, expired at $68.36. |
| e. | On December 28, 2019, 31,724 share purchase warrants, granted from a debenture issue, expired at $76.90. |
| F-37 |
|
18.
|
SHARE CAPITAL
(
cont’d
)
|
|
(e)
|
Share purchase warrants (cont’d)
|
|
|
|
|
Number of
Warrants |
|
|
Weighted
average exercise price |
|
|
|
Outstanding, December 31, 2018
|
|
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(
|
)
|
|
|
|
|
|
Expired
|
|
|
(
|
)
|
|
|
|
|
|
Outstandin
g, December 31, 2019
|
|
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
|
|
Outstanding, December 31, 2020
|
|
|
|
|
|
$
|
|
|
|
Granted
|
|
|
|
|
|
|
|
|
|
Exercised
|
|
|
(
|
)
|
|
|
|
|
|
Expired
|
|
|
(
|
)
|
|
|
|
|
|
Outstanding, December 31, 2021
|
|
|
|
|
|
$
|
|
|
|
Grant Date
|
|
Number of
Warrants outstanding and exercisable |
|
|
Exercise Price
|
|
|
Expiry date
|
|
|||
|
23-Dec-19
|
|
|
|
|
|
|
|
|
|
|
23-Dec-22
|
|
|
28-Jul-20
|
|
|
|
|
|
|
|
|
|
|
28-Jul-22
|
|
|
29-Sep-20
|
|
|
|
|
|
|
|
|
|
|
28-Sep-25
|
|
|
31-Dec-20
|
|
|
|
|
|
|
|
|
|
|
30-Jun-24
|
|
|
26-Oct-21
|
|
|
|
|
|
|
|
|
|
|
03-Nov-26
|
|
|
Total
|
|
|
|
|
|
$
|
|
|
|
|
|
|
| F-38 |
|
19.
|
COST OF SALE
S
|
|
(in thousands)
|
|
31-Dec-21
|
|
|
31-Dec-20
|
|
|
31-Dec-19
|
|
|||
|
Inventory expensed
|
|
$
|
|
|
$ |
|
$ |
|
||||
| Royalties |
|
|
|
|
|
|
||||||
| Other expenses |
|
|
|
|
|
|
||||||
|
Total
|
|
$
|
|
|
$ |
|
$ |
|
||||
|
20.
|
SELLING AND MARKETING EXPENSES
|
|
(in thousands)
|
|
31-Dec-21
|
|
|
31-Dec-20
|
|
|
31-Dec-19
|
|
|||
| Salaries and related expenses |
|
$
|
|
|
$ |
|
$ |
|
||||
| Advertising and marketing |
|
|
|
|
|
|
||||||
| Travel and conferences |
|
|
|
|
|
|
||||||
|
Total
|
|
$
|
|
|
$ |
|
$ |
|
||||
|
21.
|
GENERAL AND ADMINISTRATIVE EXPENSES
|
|
(in thousands)
|
|
31-Dec-21
|
|
|
31-Dec-20
|
|
|
31-Dec-19
|
|
|||
| Salaries and related expenses |
|
$
|
|
|
$ |
|
$ |
|
||||
| Professional services |
|
|
|
|
|
|
||||||
| Consulting and director fees |
|
|
|
|
|
|
||||||
| Management fees |
|
|
|
|
|
|
||||||
| Travel |
|
|
|
|
|
|
||||||
| Office and general |
|
|
|
|
|
|
||||||
| Regulatory and filing fees |
|
|
|
|
|
|
||||||
| Shareholder relations |
|
|
|
|
|
|
||||||
|
Total
|
|
$
|
|
|
$ |
|
$ |
|
||||
| F-39 |
|
22.
|
FINANCE EXPENSES
|
| 31-Dec-21 | 31-Dec-20 | 31-Dec-19 | ||||||||||
| Interest paid and acretive interest on debentures | $ |
|
$ |
|
$ |
|
||||||
| Interest expense on long term debt |
|
|
|
|||||||||
| Interest on bank loans |
|
|
|
|||||||||
| Other interest and bank charges |
|
(
|
) |
|
||||||||
| Loss (gain) on redemption of debentures |
|
(
|
) |
|
||||||||
| Interest earned on director's loan |
(
|
) |
(
|
) |
(
|
) | ||||||
| Interest expense on lease obligations |
|
|
|
|||||||||
| Total | $ |
|
$ |
|
$ |
|
||||||
|
23.
|
TRANSACTION COSTS
|
| F-40 |
|
24.
|
INCOME TAXES
|
|
|
|
2021
|
|
|
2020
|
|
|
2019
|
|
|||
|
Loss for the year
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
Expected income tax (recovery)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
Change in statutory, foreign tax, foreign exchange rates and other
|
|
|
|
|
|
|
(
|
)
|
|
|
|
|
|
Permanent differences
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact of flow through share
|
|
|
||||||||||
|
Share issue cost
|
|
|
-
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Impact of convertible debenture
|
|
|
(
|
)
|
|
|
|
|
|
|
|
|
|
Adjust prior years provision vs statutory tax returns and expiry of non-capital losses
|
|
|
(
|
)
|
|
|
|
|
|
|
||
|
Expiry of non-capital losses
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
Change in unrecognized deductible temporary differences
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total income tax expense (recovery)
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Current income tax
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Deferred tax recovery
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
2021
|
|
|
2020
|
|
|
2019
|
|
|||
|
Deferred tax assets (liabilities)
|
|
|
||||||||||
|
ROU assets and lease liabilities
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
$
|
(
|
)
|
|
Intangible Assets
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
||
|
Convertible Debenture
|
|
|
(
|
)
|
|
|
(
|
)
|
|
|
(
|
)
|
|
Non-capital losses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net deferred tax liability
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
2021
|
|
|
Expiry
Date Range |
|
2020
|
|
|
Expiry
Date Range |
|
2019
|
|
|
Expiry
Date Range |
|||
|
Temporary Differences
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
Receivables
|
|
$
|
|
|
|
No expiry date
|
|
$
|
|
|
|
No expiry date
|
|
$
|
-
|
|
|
No expiry date
|
|
Property, plant, and equipment and intangibles
|
|
|
|
|
|
No expiry date
|
|
|
|
|
|
No expiry date
|
|
|
|
|
|
No expiry date
|
|
Financing cost
|
|
|
|
|
|
No expiry date
|
|
|
|
|
|
2040 to 2044
|
|
|
|
|
|
2039 to 2043
|
|
Inventory
|
|
|
|
|
|
No expiry date
|
|
|
|
|
|
No expiry date
|
|
|
-
|
|
|
No expiry date
|
|
Allowance for doubtful accounts
|
|
|
|
|
|
No expiry date
|
|
|
|
|
|
No expiry date
|
|
|
-
|
|
|
No expiry date
|
|
Warrant liability
|
|
|
|
|
|
No expiry date
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Allowable capital losses
|
|
|
|
|
|
No expiry date
|
|
|
|
|
|
No expiry date
|
|
|
|
|
|
No expiry date
|
|
Non-capital losses available for future periods
|
|
|
|
|
|
No expiry date
|
|
|
|
|
|
see below
|
|
|
|
|
|
see below
|
|
Canada
|
|
|
|
|
|
2026-2041
|
|
|
|
|
|
2026 to 2040
|
|
|
|
|
|
2026 to 2039
|
|
Israel
|
|
|
|
|
|
No expiry date
|
|
|
|
|
|
No expiry date
|
|
|
|
|
|
No expiry date
|
|
United States
|
|
|
|
|
|
No expiry date
|
|
|
-
|
|
|
No expiry date
|
|
|
-
|
|
|
No expiry date
|
|
|
| F-41 |
|
25.
|
CAPITAL MANAGEMENT
|
|
26.
|
FINANCIAL INSTRUMENTS
|
|
Type
|
Valuation Technique
|
Key Inputs
|
Inter-relationship between significant inputs and fair value measurement
|
|
Convertible Promissory Note
|
The fair value of the convertible promissory note has been calculated using a binomial lattice methodology
|
Key observable inputs
·
Share price (December 31, 2021: US $
·
Risk-free interest rate (December 31, 2021:
·
Dividend yield (December 31, 2021:
Key unobservable inputs
·
Instrument specific spread (December 31, 2021:
·
Credit spread (December 31, 2021:
|
The estimated fair value would increase (decrease) if:
·
·
·
·
·
|
| F-42 |
|
26.
|
FINANCIAL INSTRUMENTS (CONT’D)
|
|
Convertible Promissory Note, December 31, 2021
|
||||||||
| Comprehensive loss | ||||||||
| Increase | Decrease | |||||||
|
Expected volatility (
|
|
(
|
) | |||||
|
Credit spread (
|
(
|
) |
|
|||||
|
Instrument specific spread (
|
(
|
) |
|
|||||
|
(in thousands)
|
|
December 31, 2021
|
|
|
December 31, 2020
|
|
||
| EMEA | $ |
|
$ |
|
||||
| Australia |
|
|
||||||
| North America |
|
|
||||||
| Total | $ |
|
$ |
|
||||
| F-43 |
|
26.
|
FINANCIAL INSTRUMENTS (CONT’D)
|
| F-44 |
|
26.
|
FINANCIAL INSTRUMENTS (CONT’D)
|
|
a)
|
Currency Risk
|
|
(in USD thousands)
|
|
USD
|
|
|
NIS
|
|
|
CAD
|
|
|
Total
|
|
||||
|
Financial assets and financial liabilities:
|
||||||||||||||||
|
Current assets
|
||||||||||||||||
| Cash and restricted cash |
|
|
|
|
||||||||||||
| Trade and other receivables |
|
|
|
|
||||||||||||
| Advances to supplier |
|
- | - |
|
||||||||||||
|
Current liabilities
|
||||||||||||||||
| Bank loan | - |
(
|
) | - |
(
|
) | ||||||||||
| Accounts payable and accrued liabilities |
(
|
) |
(
|
) |
(
|
) |
(
|
) | ||||||||
| Due to related party |
|
|
|
|||||||||||||
| Future purchase consideration |
(
|
) |
(
|
) | ||||||||||||
| Convertible debentures |
(
|
) |
|
- |
(
|
) | ||||||||||
| Warrant liability |
(
|
) |
|
- |
(
|
) | ||||||||||
|
Total
|
|
|
(
|
)
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
| 10% fluctuation in exchange rate |
|
|
(
|
)
|
|
|
|
|
|
|
(
|
)
|
|
|
(
|
)
|
|
b)
|
Interest Rate Risk
|
|
c)
|
Price Risk
|
| F-45 |
|
27.
|
RELATED PARTY TRANSACTIONS
|
|
|
|
2021
|
|
|
2020
|
|
|
2019
|
|
|||
|
|
|
|
|
|
|
|
|
|
|
|||
|
Payments to key management personnel:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries, consulting and directors’ fees
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
Share-based payments
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
(in thousands)
|
|
||||||||||
|
Type of Service
|
|
Nature of Relationship
|
|
|
2021
|
|
|
2020
|
|
|
2019
|
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
|
Selling and marketing expenses
|
|
VP Technology/VP Sales International
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
General and administrative expense
|
|
Companies controlled by the CEO, CFO and Directors
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| F-46 |
|
28.
|
SEGMENTED INFORMATION
|
|
External Revenues (in thousands)
|
|
31-Dec-21
|
|
|
31-Dec-20
|
|
|
31-Dec-19
|
|
|||
| EMEA |
|
$
|
|
|
$ |
|
$ |
|
||||
| USA |
|
|
|
|
|
|
||||||
| Canada |
|
|
|
|
|
|
||||||
| Australia and New Zealand |
|
|
|
|
|
|
||||||
| Total |
|
$
|
|
|
$ |
|
$ |
|
||||
|
Non-current assets in thousands $
|
|
2021
|
|
|
2020
|
|
||
|
Long term receivable total
|
|
$
|
|
|
|
$
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada
|
|
|
-
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
EMEA
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
Right of use assets total
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EMEA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loan to director total
|
|
$
|
-
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EMEA
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equipment total
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
EMEA
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intangibles-total
|
|
$
|
|
|
|
$
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Canada
|
|
|
|
|
|
|
-
|
|
|
|
|
|
|
|
|
|
|
|
|
EMEA
|
|
|
|
|
|
|
|
|
|
Revenues by product (in thousands)
|
|
31-Dec-21
|
|
|
31-Dec-20
|
|
|
31-Dec-19
|
|
|||
|
Cellular boosters and related accessories
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rugged devices and related accessories
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenues
|
|
$
|
|
|
|
$
|
|
|
|
$
|
|
|
| F-47 |
|
29.
|
MAJOR CUSTOMERS
|
|
30.
|
SUPPLEMENTAL INFORMATION WITH RESPECT TO CASH FLOWS
|
|
(a)
|
Recognized $910,055 in right of use assets and $833,766 in lease liabilities.
|
|
(b)
|
Issued $560,000 in share capital which was accrued in the prior year for services.
|
|
(c)
|
Issued $36,050 in share capital in settlement of debt.
|
|
(a)
|
Reclassified $40,980 from convertible debenture to share capital as the result of a conversion of $57,692 of debentures into 1,149 shares.
|
|
(b)
|
Recognized $912,916 of accretion of the convertible debentures, classified $56,471 of long-term debt, $127,776 of lease obligations and $6,160,769 of convertible debentures all as current liabilities.
|
|
(c)
|
Issued shares with a value of $710,970 and accrued shares to be issued of $560,000 in exchange for services.
|
|
(d)
|
Recognized $306,085 in right of use assets and lease liabilities.
|
|
(a)
|
Reclassified $98,068 from reserves to share capital as the fair value of agents’ options exercised during the period.
|
|
(b)
|
Reclassified $12,757 from reserves to share capital as the fair value of agents’ options that expired in the period.
|
|
(c)
|
Recognized $331,430 of accretion of the convertible debentures and classified $44,547 of long-term debt as current.
|
| F-48 |
|
31.
|
SUBSEQUENT EVENTS
|
| (a) |
On January 11, 2022, the Company completed an underwritten public offering in the United States, raising a total of $
|
|
(
b
)
|
In accordance with the terms of the convertible promissory note agreement with the Lender, as outlined in Note 14(e), in the event of any subsequent capital raises, both the conversion price and the exercise price of warrants are at a price less than the stated Conversion Price (US$
|
| (c) |
In addition, as the total gross proceeds of the common share offering, as more fully described in Note 31(a) is in excess of $
|
|
(d)
|
The company issued a total of
|
| F-49 |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|